QueryIDs	chembl_id	molregno	PubChem_ID	DrugBank_ID	Drug_Name	MOA	Action_Type	First_Approval	ChEMBL_TID	TID	UniProt_ID	Desc	Organism	Mesh_Indication	hgnc_symbol
P38484	NA	NA	NA	NA	INTERFERON GAMMA-1B	Interferon gamma receptor agonist	AGONIST	1999	CHEMBL2364171	106150	P38484	Interferon gamma receptor 2	Homo sapiens	D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D003550: Cystic Fibrosis,D005185: Fallopian Tube Neoplasms,D005621: Friedreich Ataxia,D006105: Granulomatous Disease, Chronic,D007938: Leukemia,D008103: Liver Cirrhosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009164: Mycobacterium Infections,D009182: Mycosis Fungoides,D009369: Neoplasms,D009447: Neuroblastoma,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011565: Psoriasis,D011658: Pulmonary Fibrosis,D012162: Retinal Degeneration,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D014605: Uveitis,D014606: Uveitis, Anterior,D014987: Xerostomia,D015270: Mycobacterium avium-intracellulare Infection,D015658: HIV Infections,D016918: Arthritis, Reactive,D016919: Meningitis, Cryptococcal,D018370: Leukocyte-Adhesion Deficiency Syndrome,D019698: Hepatitis C, Chronic,D054990: Idiopathic Pulmonary Fibrosis,D058387: Candidemia,D064129: Prostatic Neoplasms, Castration-Resistant	IFNGR2
P21917	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD4
P21917	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD4
P21917	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD4
P21917	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD4
P21917	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD4
P21917	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD4
P21917	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD4
P21917	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD4
P21917	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4
P21917	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD4
P21917	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4
P21917	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD4
P21917	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD4
P21917	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4
P21917	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4
P21917	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD4
P21917	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD4
P21917	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD4
P21917	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4
P28065	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9
P28065	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9
P28065	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB9
P28702	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D011565: Psoriasis	RXRB
P28702	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRB
P28702	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRB
P28702	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRB
P49720	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3
P49720	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3
P49720	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB3
P07947	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07947	Tyrosine-protein kinase Yes	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	YES1
P43686	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4
P43686	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4
P43686	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC4
Q96F46	NA	NA	NA	NA	BRODALUMAB	Interleukin-17 receptor A antagonist	ANTAGONIST	2017	CHEMBL3580485	109781	Q96F46	Interleukin-17 receptor A	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D003424: Crohn Disease,D007154: Immune System Diseases,D011565: Psoriasis,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa	IL17RA
P39086	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	P39086	Glutamate receptor ionotropic, kainate 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK1
P60880	NA	NA	NA	NA	ONABOTULINUMTOXINA	Synaptosomal-associated protein 25 inhibitor	INHIBITOR	1991	CHEMBL2364159	106138	P60880	Synaptosomal-associated protein 25	Homo sapiens	D000070636: Rotator Cuff Injuries,D000152: Acne Vulgaris,D000375: Aging,D000505: Alopecia,D001145: Arrhythmias, Cardiac,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D001750: Urinary Bladder, Neurogenic,D001764: Blepharospasm,D001930: Brain Injuries,D002054: Burning Mouth Syndrome,D002062: Bursitis,D002349: Carpal Tunnel Syndrome,D002547: Cerebral Palsy,D002921: Cicatrix,D003161: Compartment Syndromes,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004938: Esophageal Neoplasms,D004948: Esotropia,D005157: Facial Pain,D005242: Fecal Incontinence,D005401: Fissure in Ano,D006099: Granuloma,D006261: Headache,D006429: Hemiplegia,D006562: Herpes Zoster,D006945: Hyperhidrosis,D007172: Erectile Dysfunction,D007592: Joint Diseases,D007766: Lacrimal Apparatus Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009120: Muscle Cramp,D009128: Muscle Spasticity,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009298: Nasal Polyps,D009422: Nervous System Diseases,D009437: Neuralgia,D009463: Neuroma,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010146: Pain,D010300: Parkinson Disease,D010411: Penile Induration,D011470: Prostatic Hyperplasia,D011472: Prostatitis,D011537: Pruritus,D011565: Psoriasis,D011928: Raynaud Disease,D012004: Rectal Neoplasms,D012021: Reflex, Abnormal,D012148: Restless Legs Syndrome,D012220: Rhinitis,D012222: Rhinitis, Atrophic,D012594: Scleroderma, Localized,D012798: Sialorrhea,D012868: Skin Abnormalities,D012891: Sleep Apnea Syndromes,D013119: Spinal Cord Injuries,D013274: Stomach Neoplasms,D013285: Strabismus,D013716: Tennis Elbow,D013901: Thoracic Outlet Syndrome,D014103: Torticollis,D014202: Tremor,D014277: Trigeminal Neuralgia,D014456: Ulcer,D014549: Urinary Incontinence,D014826: Vocal Cord Paralysis,D014947: Wounds and Injuries,D015352: Dry Eye Syndromes,D015595: Skin Aging,D016055: Urinary Retention,D017116: Low Back Pain,D017180: Tachycardia, Ventricular,D018589: Gastroparesis,D018856: Cystitis, Interstitial,D019214: Gingival Overgrowth,D020069: Shoulder Pain,D020329: Essential Tremor,D020370: Osteoarthritis, Knee,D020521: Stroke,D020773: Headache Disorders,D036981: Fasciitis, Plantar,D046788: Patellofemoral Pain Syndrome,D049970: Graves Ophthalmopathy,D052256: Tendinopathy,D053201: Urinary Bladder, Overactive,D053202: Urinary Incontinence, Urge,D059350: Chronic Pain	SNAP25
P60880	NA	NA	NA	NA	INCOBOTULINUMTOXINA	Synaptosomal-associated protein 25 inhibitor	INHIBITOR	2010	CHEMBL2364159	106138	P60880	Synaptosomal-associated protein 25	Homo sapiens	D001764: Blepharospasm,D001883: Borderline Personality Disorder,D009128: Muscle Spasticity,D010146: Pain,D010300: Parkinson Disease,D012393: Rosacea,D012891: Sleep Apnea Syndromes,D012913: Snoring,D014103: Torticollis,D014202: Tremor,D014277: Trigeminal Neuralgia,D020329: Essential Tremor,D020521: Stroke,D020821: Dystonic Disorders,D053201: Urinary Bladder, Overactive	SNAP25
P60880	NA	NA	NA	NA	ABOBOTULINUMTOXINA	Synaptosomal-associated protein 25 inhibitor	INHIBITOR	2009	CHEMBL2364159	106138	P60880	Synaptosomal-associated protein 25	Homo sapiens	D002921: Cicatrix,D013716: Tennis Elbow,D017116: Low Back Pain	SNAP25
P60880	NA	NA	NA	NA	PRABOTULINUMTOXIN A	Synaptosomal-associated protein 25 proteolytic enzyme	PROTEOLYTIC ENZYME	2019	CHEMBL2364159	106138	P60880	Synaptosomal-associated protein 25	Homo sapiens	D015595: Skin Aging	SNAP25
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB
Q9P0X4	NA	NA	NA	NA	TRIMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1946	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D004827: Epilepsy	CACNA1I
Q9P0X4	NA	NA	NA	NA	ETHOSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1960	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D003866: Depressive Disorder,D004827: Epilepsy,D004832: Epilepsy, Absence,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome	CACNA1I
Q9P0X4	NA	NA	NA	NA	METHSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1957	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D004827: Epilepsy	CACNA1I
Q9P0X4	NA	NA	NA	NA	PHENSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1982	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D004827: Epilepsy	CACNA1I
Q9P0X4	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1I
Q9P0X4	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1I
Q9P0X4	NA	NA	NA	NA	PARAMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1949	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D004827: Epilepsy	CACNA1I
Q9P0X4	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1I
Q9P0X4	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	NA	CACNA1I
Q9P0X4	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	NA	CACNA1I
Q9P0X4	NA	NA	NA	NA	MIBEFRADIL DIHYDROCHLORIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1997	CHEMBL2362995	105707	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	NA	CACNA1I
Q9P0X4	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9P0X4	Voltage-dependent T-type calcium channel subunit alpha-1I	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1I
Q13464	NA	NA	NA	NA	NETARSUDIL DIMESYLATE	Rho-associated protein kinase inhibitor	INHIBITOR	2017	CHEMBL2111459	104981	Q13464	Rho-associated protein kinase 1	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ROCK1
P08572	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A2
P08572	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A2
P21709	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P21709	Ephrin type-A receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA1
P00813	NA	NA	NA	NA	PENTOSTATIN	Adenosine deaminase inhibitor	INHIBITOR	1991	CHEMBL1910	14	P00813	Adenosine deaminase	Homo sapiens	D000755: Anemia, Sickle Cell,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell	ADA
P28331	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	P28331	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS1
P02462	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A1
P02462	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A1
P01589	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RA
P01589	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RA
P01589	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RA
P01589	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RA
P32245	NA	NA	NA	NA	BREMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009325: Nausea,D012735: Sexual Dysfunction, Physiological	MC4R
P32245	NA	NA	NA	NA	SETMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity,D009767: Obesity, Morbid,D011218: Prader-Willi Syndrome,D051437: Renal Insufficiency,D058496: Smith-Magenis Syndrome	MC4R
P32245	NA	NA	NA	NA	BREMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D020018: Sexual Dysfunctions, Psychological	MC4R
P32245	NA	NA	NA	NA	SETMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity	MC4R
P00742	NA	NA	NA	NA	RIVAROXABAN	Coagulation factor X inhibitor	INHIBITOR	2011	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000082862: Aortic Valve Disease,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001281: Atrial Fibrillation,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D008103: Liver Cirrhosis,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D009767: Obesity, Morbid,D011655: Pulmonary Embolism,D012214: Rheumatic Heart Disease,D013921: Thrombocytopenia,D013923: Thromboembolism,D013927: Thrombosis,D016736: Antiphospholipid Syndrome,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D058729: Peripheral Arterial Disease	F10
P00742	NA	NA	NA	NA	APIXABAN	Coagulation factor X inhibitor	INHIBITOR	2012	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D009404: Nephrotic Syndrome,D011655: Pulmonary Embolism,D013923: Thromboembolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054092: Foramen Ovale, Patent,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054549: Takotsubo Cardiomyopathy,D054556: Venous Thromboembolism	F10
P00742	NA	NA	NA	NA	BETRIXABAN	Coagulation factor X inhibitor	INHIBITOR	2017	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006470: Hemorrhage,D007674: Kidney Diseases,D008107: Liver Diseases,D013923: Thromboembolism,D013927: Thrombosis,D054556: Venous Thromboembolism	F10
P00742	NA	NA	NA	NA	EDOXABAN TOSYLATE	Coagulation factor X inhibitor	INHIBITOR	2015	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D004617: Embolism,D011655: Pulmonary Embolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D054556: Venous Thromboembolism	F10
P00742	NA	NA	NA	NA	EMICIZUMAB	Coagulation factor IX and X other	OTHER	2017	CHEMBL2111424	104934	P00742	Coagulation factor X	Homo sapiens	D006467: Hemophilia A,D006470: Hemorrhage	F10
P36888	NA	NA	NA	NA	SUNITINIB MALATE	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2006	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT3
P36888	NA	NA	NA	NA	MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2017	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	FLT3
P36888	NA	NA	NA	NA	SORAFENIB TOSYLATE	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2005	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT3
P36888	NA	NA	NA	NA	FEDRATINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2019	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D011087: Polycythemia Vera,D055728: Primary Myelofibrosis	FLT3
P36888	NA	NA	NA	NA	GILTERITINIB FUMARATE	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2018	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D015470: Leukemia, Myeloid, Acute	FLT3
P36888	NA	NA	NA	NA	GILTERITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2018	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D001752: Blast Crisis,D002289: Carcinoma, Non-Small-Cell Lung,D007674: Kidney Diseases,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute	FLT3
P36888	NA	NA	NA	NA	PEXIDARTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2019	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT3
P36888	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2019	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	FLT3
P36888	NA	NA	NA	NA	FEDRATINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	2019	CHEMBL1974	12670	P36888	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens	D055728: Primary Myelofibrosis	FLT3
P47871	NA	NA	NA	NA	GLUCAGON	Glucagon receptor agonist	AGONIST	1998	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003139: Common Cold,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia,D009765: Obesity,D044903: Congenital Hyperinsulinism,D046768: Nesidioblastosis	GCGR
P47871	NA	NA	NA	NA	GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	1960	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia	GCGR
P47871	NA	NA	NA	NA	DASIGLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	2021	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D007003: Hypoglycemia	GCGR
P05108	NA	NA	NA	NA	AMINOGLUTETHIMIDE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1980	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1
P05108	NA	NA	NA	NA	MITOTANE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1970	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D002277: Carcinoma,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1
Q13936	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1C
Q13936	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1C
Q13936	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1C
Q13936	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1C
Q13936	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1C
Q13936	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C
Q13936	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1C
Q13936	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1C
Q13936	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1C
Q13936	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C
Q13936	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C
Q13936	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1C
Q13936	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C
Q13936	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1C
Q13936	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C
Q13936	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C
Q13936	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation	CACNA1C
Q13936	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1C
Q13936	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1C
Q13936	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C
Q13936	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C
Q14721	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNB1
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNB1
Q14721	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	NA	KCNB1
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNB1
Q9BY41	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC8
Q9BY41	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC8
Q9BY41	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D009101: Multiple Myeloma	HDAC8
O60391	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN3B
O60391	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN3B
O60391	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN3B
O60391	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN3B
O60391	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN3B
O60391	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D010146: Pain	GRIN3B
O60391	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D010300: Parkinson Disease	GRIN3B
O60391	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D000437: Alcoholism	GRIN3B
O60391	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O60391	Glutamate receptor ionotropic, NMDA 3B	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN3B
P28223	NA	NA	NA	NA	CLOZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1989	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	HTR2A
P28223	NA	NA	NA	NA	THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	HTR2A
P28223	NA	NA	NA	NA	CHLORPROMAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	HTR2A
P28223	NA	NA	NA	NA	RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1993	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	HTR2A
P28223	NA	NA	NA	NA	ILOPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A
P28223	NA	NA	NA	NA	MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	HTR2A
P28223	NA	NA	NA	NA	OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	HTR2A
P28223	NA	NA	NA	NA	LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	HTR2A
P28223	NA	NA	NA	NA	CHLORPROTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	DROPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	HTR2A
P28223	NA	NA	NA	NA	ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	HTR2A
P28223	NA	NA	NA	NA	THIOTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders	HTR2A
P28223	NA	NA	NA	NA	PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1984	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR2A
P28223	NA	NA	NA	NA	PALIPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2006	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1974	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1956	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1994	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	CYCLOBENZAPRINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1977	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D002547: Cerebral Palsy,D008881: Migraine Disorders,D009128: Muscle Spasticity,D013035: Spasm,D013118: Spinal Cord Diseases,D063806: Myalgia	HTR2A
P28223	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1981	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	HTR2A
P28223	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1979	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	HALOPERIDOL DECANOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1986	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1976	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	LOXAPINE SUCCINATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1959	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2001	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder	HTR2A
P28223	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2010	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	BREXPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	HTR2A
P28223	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	CARPHENAZINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1982	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	PIMAVANSERIN TARTRATE	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	2016	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D010300: Parkinson Disease,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	QUETIAPINE FUMARATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1997	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A
P28223	NA	NA	NA	NA	LUMATEPERONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2019	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	ASENAPINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	OLANZAPINE PAMOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A
P28223	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A
P28223	NA	NA	NA	NA	HALOPERIDOL LACTATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A
P62333	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6
P62333	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6
P62333	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC6
Q9NZQ7	NA	NA	NA	NA	DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	INHIBITOR	2017	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D001005: Anus Neoplasms,D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D004407: Dysgerminoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016889: Endometrial Neoplasms,D018239: Seminoma,D018262: Adenocarcinoma, Clear Cell,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018358: Neuroendocrine Tumors,D019337: Hematologic Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	CD274
Q9NZQ7	NA	NA	NA	NA	ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	INHIBITOR	2016	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	CD274
Q9NZQ7	NA	NA	NA	NA	AVELUMAB	Programmed cell death 1 ligand 1 other	OTHER	2017	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007890: Leiomyosarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008579: Meningioma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D031901: Gestational Trophoblastic Disease,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	CD274
P14784	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RB
P14784	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RB
P14784	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RB
P14784	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RB
P32745	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR3
P32745	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 3 agonist	AGONIST	2012	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	NA	SSTR3
P32745	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 3 agonist	AGONIST	2014	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly	SSTR3
P32745	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR3
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3
P29274	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2A
P29274	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A
P29274	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29274	Adenosine receptor A2a	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A
P29274	NA	NA	NA	NA	ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ANTAGONIST	2019	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D008107: Liver Diseases,D010300: Parkinson Disease,D019966: Substance-Related Disorders	ADORA2A
P29274	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2A
P29274	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2A
P29274	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2A
P29274	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	NA	ADORA2A
P29274	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2A
P29274	NA	NA	NA	NA	REGADENOSON	Adenosine A2a receptor agonist	AGONIST	2008	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D002318: Cardiovascular Diseases	ADORA2A
Q8NCM2	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNH5
Q8NCM2	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNH5
Q8NCM2	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	NA	KCNH5
Q8NCM2	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNH5
P06213	NA	NA	NA	NA	INSULIN LISPRO	Insulin receptor agonist	AGONIST	1996	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006943: Hyperglycemia	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1987	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN GLARGINE	Insulin receptor agonist	AGONIST	2000	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D007938: Leukemia,D008223: Lymphoma,D009203: Myocardial Infarction,D011236: Prediabetic State,D050197: Atherosclerosis	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	Insulin receptor agonist	AGONIST	1985	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D050197: Atherosclerosis	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D016640: Diabetes, Gestational	INSR
P06213	NA	NA	NA	NA	INSULIN ASPART	Insulin receptor agonist	AGONIST	2000	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000544: Alzheimer Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D007938: Leukemia,D008223: Lymphoma,D016640: Diabetes, Gestational,D050197: Atherosclerosis	INSR
P06213	NA	NA	NA	NA	INSULIN ASPART PROTAMINE RECOMBINANT	Insulin receptor agonist	AGONIST	2001	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN LISPRO PROTAMINE RECOMBINANT	Insulin receptor agonist	AGONIST	1999	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	INSR
P06213	NA	NA	NA	NA	INSULIN PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR
P06213	NA	NA	NA	NA	INSULIN PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007333: Insulin Resistance	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN	Insulin receptor agonist	AGONIST	1983	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000083242: Ischemic Stroke,D000789: Angina, Unstable,D001714: Bipolar Disorder,D002056: Burns,D002349: Carpal Tunnel Syndrome,D003327: Coronary Disease,D003693: Delirium,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D005901: Glaucoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006946: Hyperinsulinism,D006947: Hyperkalemia,D006949: Hyperlipidemias,D006973: Hypertension,D007003: Hypoglycemia,D007006: Hypogonadism,D007333: Insulin Resistance,D009203: Myocardial Infarction,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D012559: Schizophrenia,D012772: Shock, Septic,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D016640: Diabetes, Gestational,D018923: Persian Gulf Syndrome,D019578: Multiple System Atrophy,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D047928: Premature Birth,D050197: Atherosclerosis,D054058: Acute Coronary Syndrome,D055948: Sarcopenia,D058186: Acute Kidney Injury,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC BEEF/PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PROMPT PURIFIED PORK	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED BEEF/PORK	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE BEEF/PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED PURIFIED BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN GLULISINE	Insulin receptor agonist	AGONIST	2004	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000544: Alzheimer Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004314: Down Syndrome,D009203: Myocardial Infarction	INSR
P06213	NA	NA	NA	NA	INSULIN PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D050197: Atherosclerosis	INSR
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PROMPT BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1985	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR
P06213	NA	NA	NA	NA	INSULIN DETEMIR	Insulin receptor agonist	AGONIST	2005	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	INSR
P06213	NA	NA	NA	NA	INSULIN DEGLUDEC	Insulin receptor agonist	AGONIST	2015	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2	INSR
Q96DB2	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC11
Q96DB2	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC11
Q96DB2	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D009101: Multiple Myeloma	HDAC11
P48551	NA	NA	NA	NA	INTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D003218: Condylomata Acuminata,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008103: Liver Cirrhosis,D008113: Liver Neoplasms,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012514: Sarcoma, Kaposi,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IFNAR2
P48551	NA	NA	NA	NA	INTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	1996	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000544: Alzheimer Disease,D001249: Asthma,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D006526: Hepatitis C,D009102: Multiple Organ Failure,D009103: Multiple Sclerosis,D012128: Respiratory Distress Syndrome,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome	IFNAR2
P48551	NA	NA	NA	NA	PEGINTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	2002	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D003015: Clostridium Infections,D003110: Colonic Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D006505: Hepatitis,D006509: Hepatitis B,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007239: Infections,D007680: Kidney Neoplasms,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D013921: Thrombocytopenia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D055728: Primary Myelofibrosis	IFNAR2
P48551	NA	NA	NA	NA	INTERFERON BETA-1B	Interferon alpha/beta receptor agonist	AGONIST	1993	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D009103: Multiple Sclerosis,D009202: Cardiomyopathies,D015658: HIV Infections,D018352: Coronavirus Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	IFNAR2
P48551	NA	NA	NA	NA	INTERFERON ALFACON-1	Interferon alpha/beta receptor agonist	AGONIST	1997	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D006526: Hepatitis C,D007251: Influenza, Human,D019698: Hepatitis C, Chronic	IFNAR2
P48551	NA	NA	NA	NA	PEGINTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	2001	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003397: Craniopharyngioma,D003699: Hepatitis D,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006505: Hepatitis,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D012516: Osteosarcoma,D013920: Thrombocythemia, Essential,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D055728: Primary Myelofibrosis	IFNAR2
P48551	NA	NA	NA	NA	INTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D001528: Behcet Syndrome,D002292: Carcinoma, Renal Cell,D006526: Hepatitis C,D007680: Kidney Neoplasms,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011565: Psoriasis,D015658: HIV Infections,D019698: Hepatitis C, Chronic,D031300: Retinal Vasculitis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	IFNAR2
P48551	NA	NA	NA	NA	PEGINTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	2014	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	IFNAR2
P48551	NA	NA	NA	NA	INTERFERON ALFA-N3	Interferon alpha/beta receptor agonist	AGONIST	1989	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	IFNAR2
P17181	NA	NA	NA	NA	INTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D003218: Condylomata Acuminata,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008103: Liver Cirrhosis,D008113: Liver Neoplasms,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012514: Sarcoma, Kaposi,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IFNAR1
P17181	NA	NA	NA	NA	INTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	1996	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000544: Alzheimer Disease,D001249: Asthma,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D006526: Hepatitis C,D009102: Multiple Organ Failure,D009103: Multiple Sclerosis,D012128: Respiratory Distress Syndrome,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome	IFNAR1
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	2002	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D003015: Clostridium Infections,D003110: Colonic Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D006505: Hepatitis,D006509: Hepatitis B,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007239: Infections,D007680: Kidney Neoplasms,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D013921: Thrombocytopenia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D055728: Primary Myelofibrosis	IFNAR1
P17181	NA	NA	NA	NA	INTERFERON BETA-1B	Interferon alpha/beta receptor agonist	AGONIST	1993	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D009202: Cardiomyopathies,D015658: HIV Infections,D018352: Coronavirus Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	IFNAR1
P17181	NA	NA	NA	NA	INTERFERON ALFACON-1	Interferon alpha/beta receptor agonist	AGONIST	1997	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D006526: Hepatitis C,D007251: Influenza, Human,D019698: Hepatitis C, Chronic	IFNAR1
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	2001	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003397: Craniopharyngioma,D003699: Hepatitis D,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006505: Hepatitis,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D012516: Osteosarcoma,D013920: Thrombocythemia, Essential,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D055728: Primary Myelofibrosis	IFNAR1
P17181	NA	NA	NA	NA	INTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D001528: Behcet Syndrome,D002292: Carcinoma, Renal Cell,D006526: Hepatitis C,D007680: Kidney Neoplasms,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011565: Psoriasis,D015658: HIV Infections,D019698: Hepatitis C, Chronic,D031300: Retinal Vasculitis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	IFNAR1
P17181	NA	NA	NA	NA	PEGINTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	2014	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	IFNAR1
P17181	NA	NA	NA	NA	INTERFERON ALFA-N3	Interferon alpha/beta receptor agonist	AGONIST	1989	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	IFNAR1
P10826	CHEMBL4068170	2208081	24964084	NA	TRETINOIN	Retinoic acid receptor agonist	AGONIST	1971	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004646: Emphysema,D006937: Hypercholesterolemia,D007680: Kidney Neoplasms,D007911: Lentigo,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008548: Melanosis,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009447: Neuroblastoma,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012393: Rosacea,D015209: Cholangitis, Sclerosing,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016553: Purpura, Thrombocytopenic, Idiopathic,D017495: Hyperpigmentation,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	RARB
P10826	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D011565: Psoriasis	RARB
P10826	NA	NA	NA	NA	ISOTRETINOIN	Retinoic acid receptor agonist	AGONIST	1982	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D000544: Alzheimer Disease,D001254: Astrocytoma,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002578: Uterine Cervical Dysplasia,D002583: Uterine Cervical Neoplasms,D004646: Emphysema,D004820: Epidermolysis Bullosa,D005909: Glioblastoma,D005910: Glioma,D005923: Glomerulosclerosis, Focal Segmental,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007057: Ichthyosis,D007239: Infections,D007680: Kidney Neoplasms,D007713: Klinefelter Syndrome,D007938: Leukemia,D008175: Lung Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D012393: Rosacea,D014008: Tinea Pedis,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D045169: Severe Acute Respiratory Syndrome,D053713: Azoospermia,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055623: Keratosis, Actinic,D064129: Prostatic Neoplasms, Castration-Resistant	RARB
P10826	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RARB
P10826	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RARB
P10826	NA	NA	NA	NA	ADAPALENE	Retinoic acid receptor agonist	AGONIST	1996	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D012871: Skin Diseases	RARB
P10826	NA	NA	NA	NA	TAZAROTENE	Retinoic acid receptor agonist	AGONIST	1997	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D007911: Lentigo,D011565: Psoriasis,D012871: Skin Diseases,D012878: Skin Neoplasms,D016410: Lymphoma, T-Cell, Cutaneous,D017496: Hypopigmentation	RARB
Q02223	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tumor necrosis factor receptor superfamily member 17 binding agent	BINDING AGENT	2020	CHEMBL4523587	119306	Q02223	Tumor necrosis factor receptor superfamily member 17	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TNFRSF17
Q05513	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	Q05513	Protein kinase C zeta type	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKCZ
Q16186	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	ADRM1
Q16186	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ADRM1
Q16186	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	ADRM1
P25092	NA	NA	NA	NA	PLECANATIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2017	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C
P25092	NA	NA	NA	NA	LINACLOTIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2012	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D000236: Adenoma,D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C
P31644	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA5
P31644	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA5
P31644	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA5
P31644	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D004827: Epilepsy	GABRA5
P31644	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA5
P31644	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA5
P31644	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D008881: Migraine Disorders	GABRA5
P31644	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA5
P31644	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA5
P31644	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA5
P31644	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA5
P31644	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA5
P31644	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA5
P31644	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA5
P31644	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000647: Amnesia	GABRA5
P31644	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA5
P31644	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA5
P31644	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA5
P31644	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety	GABRA5
P31644	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety	GABRA5
P31644	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety	GABRA5
P31644	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA5
P31644	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA5
P31644	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA5
P31644	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA5
P31644	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA5
P31644	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA5
P31644	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA5
P31644	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA5
P31644	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D000437: Alcoholism	GABRA5
P31644	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P31644	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA5
P31644	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P31644	Gamma-aminobutyric acid receptor subunit alpha-5	Homo sapiens	NA	GABRA5
P27815	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE4A
P27815	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE4A
P27815	NA	NA	NA	NA	AMLEXANOX	Phosphodiesterase 4 inhibitor	INHIBITOR	1996	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive,D013280: Stomatitis	PDE4A
P27815	NA	NA	NA	NA	ROFLUMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2011	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D001249: Asthma,D001987: Bronchiectasis,D003704: Dementia,D003865: Depressive Disorder, Major,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D008173: Lung Diseases, Obstructive,D008223: Lymphoma,D009369: Neoplasms,D009422: Nervous System Diseases,D009765: Obesity,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	PDE4A
P27815	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE4A
P27815	NA	NA	NA	NA	APREMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2014	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000152: Acne Vulgaris,D000437: Alcoholism,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003093: Colitis, Ulcerative,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004485: Eczema,D006073: Gout,D007154: Immune System Diseases,D008010: Lichen Planus,D008179: Lupus Erythematosus, Discoid,D011472: Prostatitis,D011565: Psoriasis,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013281: Stomatitis, Aphthous,D014605: Uveitis,D014820: Vitiligo,D015535: Arthritis, Psoriatic,D017449: Dermatitis, Allergic Contact,D017497: Hidradenitis Suppurativa,D017676: Lichen Planus, Oral,D045169: Severe Acute Respiratory Syndrome	PDE4A
P27815	NA	NA	NA	NA	CRISABOROLE	Phosphodiesterase 4 inhibitor	INHIBITOR	2016	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000506: Alopecia Areata,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D012594: Scleroderma, Localized	PDE4A
P27815	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1951	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4A
P27815	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1981	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4A
P27815	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 4 inhibitor	INHIBITOR	1982	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	NA	PDE4A
P27815	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 4 inhibitor	INHIBITOR	1970	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	NA	PDE4A
P27815	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE4A
P34903	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA3
P34903	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA3
P34903	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA3
P34903	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy	GABRA3
P34903	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA3
P34903	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA3
P34903	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D008881: Migraine Disorders	GABRA3
P34903	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA3
P34903	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA3
P34903	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA3
P34903	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA3
P34903	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA3
P34903	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA3
P34903	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA3
P34903	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia	GABRA3
P34903	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA3
P34903	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA3
P34903	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA3
P34903	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3
P34903	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3
P34903	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3
P34903	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA3
P34903	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA3
P34903	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA3
P34903	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA3
P34903	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA3
P34903	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA3
P34903	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA3
P34903	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA3
P34903	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism	GABRA3
P34903	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
P34903	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA3
P34903	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3
Q8TAA3	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q8TAA3	Proteasome subunit alpha-type 8	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA8
Q8TAA3	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q8TAA3	Proteasome subunit alpha-type 8	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA8
Q8TAA3	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q8TAA3	Proteasome subunit alpha-type 8	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA8
P28472	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB3
P28472	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB3
P28472	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB3
P28472	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy	GABRB3
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB3
P28472	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB3
P28472	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D008881: Migraine Disorders	GABRB3
P28472	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB3
P28472	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB3
P28472	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB3
P28472	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB3
P28472	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB3
P28472	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB3
P28472	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB3
P28472	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia	GABRB3
P28472	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB3
P28472	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB3
P28472	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB3
P28472	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3
P28472	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3
P28472	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3
P28472	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB3
P28472	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB3
P28472	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB3
P28472	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB3
P28472	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB3
P28472	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB3
P28472	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB3
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB3
P28472	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism	GABRB3
P28472	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P28472	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB3
P28472	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3
P30872	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR1
P30872	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 1 agonist	AGONIST	2012	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	NA	SSTR1
P30872	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 1 agonist	AGONIST	2014	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly	SSTR1
P30872	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR1
P21918	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21918	D(1B) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD5
P21918	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21918	D(1B) dopamine receptor	Homo sapiens	NA	DRD5
P21918	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21918	D(1B) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD5
P21918	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21918	D(1B) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD5
O00217	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O00217	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS8
P62191	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC1
P62191	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC1
P62191	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC1
Q99808	NA	NA	NA	NA	DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	INHIBITOR	1961	CHEMBL1997	175	Q99808	Equilibrative nucleoside transporter 1	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	SLC29A1
P07948	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	2010	CHEMBL3905	11842	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	LYN
P07948	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	LYN
Q16795	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q16795	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA9
P42345	NA	NA	NA	NA	PERHEXILINE MALEATE	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	1974	CHEMBL2842	11400	P42345	Serine/threonine-protein kinase mTOR	Homo sapiens	NA	MTOR
P07202	NA	NA	NA	NA	METHIMAZOLE	Thyroid peroxidase inhibitor	INHIBITOR	1950	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D003882: Dermatomyositis,D005909: Glioblastoma,D013959: Thyroid Diseases,D049970: Graves Ophthalmopathy	TPO
P07202	NA	NA	NA	NA	PROPYLTHIOURACIL	Thyroid peroxidase inhibitor	INHIBITOR	1947	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D013959: Thyroid Diseases,D013971: Thyrotoxicosis,D049970: Graves Ophthalmopathy	TPO
Q969S8	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC10
Q969S8	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC10
Q969S8	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D009101: Multiple Myeloma	HDAC10
O43242	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD3
O43242	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD3
O43242	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD3
Q15759	NA	NA	NA	NA	REGORAFENIB	MAP kinase p38 beta inhibitor	INHIBITOR	2012	CHEMBL3961	10120	Q15759	Mitogen-activated protein kinase 11	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	MAPK11
P18825	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2C
P18825	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2C
P18825	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2C
P18825	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2C
P18825	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2C
P18825	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2C
P18825	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2C
P18825	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2C
P18825	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2C
P18825	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2C
P18825	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2C
P18825	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2C
P18825	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2C
P18825	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2C
P18825	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2C
P18825	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2C
P18825	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2C
P18825	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2C
P18825	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2C
P18825	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2C
P18825	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2C
P18825	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P18825	Alpha-2C adrenergic receptor	Homo sapiens	NA	ADRA2C
P18825	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P18825	Alpha-2C adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2C
P10912	NA	NA	NA	NA	SOMATREM	Growth hormone receptor agonist	AGONIST	1985	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	NA	GHR
P10912	NA	NA	NA	NA	PEGVISOMANT	Growth hormone receptor antagonist	ANTAGONIST	2003	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D005359: Fibrous Dysplasia, Polyostotic,D008175: Lung Neoplasms,D010900: Pituitary Diseases,D011471: Prostatic Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms	GHR
P10912	NA	NA	NA	NA	SOMATROPIN	Growth hormone receptor agonist	AGONIST	1976	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D000375: Aging,D000690: Amyotrophic Lateral Sclerosis,D001930: Brain Injuries,D002056: Burns,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D004392: Dwarfism,D004393: Dwarfism, Pituitary,D004700: Endocrine System Diseases,D005317: Fetal Growth Retardation,D006130: Growth Disorders,D006333: Heart Failure,D007018: Hypopituitarism,D007236: Infant, Small for Gestational Age,D007246: Infertility,D007247: Infertility, Female,D008103: Liver Cirrhosis,D009087: Mucopolysaccharidosis VI,D009134: Muscular Atrophy, Spinal,D009634: Noonan Syndrome,D009765: Obesity,D010013: Osteogenesis Imperfecta,D010900: Pituitary Diseases,D011218: Prader-Willi Syndrome,D012778: Short Bowel Syndrome,D013119: Spinal Cord Injuries,D013978: Tibial Fractures,D014424: Turner Syndrome,D015658: HIV Infections,D019247: HIV Wasting Syndrome,D020370: Osteoarthritis, Knee,D020391: Muscular Dystrophy, Facioscapulohumeral,D051436: Renal Insufficiency, Chronic,D052256: Tendinopathy,D055948: Sarcopenia,D060825: Cognitive Dysfunction	GHR
P10912	NA	NA	NA	NA	SOMAPACITAN	Growth hormone receptor agonist	AGONIST	2020	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D004393: Dwarfism, Pituitary	GHR
P08913	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2A
P08913	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2A
P08913	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2A
P08913	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2A
P08913	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2A
P08913	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2A
P08913	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2A
P08913	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2A
P08913	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2A
P08913	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2A
P08913	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2A
P08913	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2A
P08913	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2A
P08913	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2A
P08913	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2A
P08913	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2A
P08913	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2A
P08913	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2A
P08913	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2A
P08913	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2A
P08913	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2A
P08913	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A
P08913	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2A
Q9Y698	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG2
Q9Y698	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG2
Q9Y698	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG2
Q9Y698	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	NA	CACNG2
Q9Y698	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	NA	CACNG2
Q9Y698	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG2
Q15054	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3
Q15054	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD3
Q15054	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD3
Q15054	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3
P11387	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	DNA topoisomerase I inhibitor	INHIBITOR	2020	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1
P11387	NA	NA	NA	NA	IRINOTECAN HYDROCHLORIDE	DNA topoisomerase I inhibitor	INHIBITOR	1996	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003967: Diarrhea,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007119: Immunoblastic Lymphadenopathy,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008527: Medulloblastoma,D008545: Melanoma,D008579: Meningioma,D008637: Mesenchymoma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018278: Carcinoma, Neuroendocrine,D018289: Carcinoma, Verrucous,D018304: Esthesioneuroblastoma, Olfactory,D018305: Ganglioneuroblastoma,D018308: Papilloma, Inverted,D018316: Gliosarcoma,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1
P11387	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	DNA topoisomerase I inhibitor	INHIBITOR	2019	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	TOP1
Q9UJ96	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UJ96	Potassium voltage-gated channel subfamily G member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG2
Q9UJ96	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UJ96	Potassium voltage-gated channel subfamily G member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG2
Q9UJ96	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UJ96	Potassium voltage-gated channel subfamily G member 2	Homo sapiens	NA	KCNG2
Q9UJ96	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UJ96	Potassium voltage-gated channel subfamily G member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG2
P18505	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB1
P18505	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB1
P18505	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB1
P18505	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D004827: Epilepsy	GABRB1
P18505	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB1
P18505	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB1
P18505	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D008881: Migraine Disorders	GABRB1
P18505	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB1
P18505	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB1
P18505	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB1
P18505	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB1
P18505	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB1
P18505	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB1
P18505	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB1
P18505	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000647: Amnesia	GABRB1
P18505	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB1
P18505	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB1
P18505	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB1
P18505	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety	GABRB1
P18505	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety	GABRB1
P18505	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety	GABRB1
P18505	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB1
P18505	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB1
P18505	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB1
P18505	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB1
P18505	NA	NA	NA	NA	ZALEPLON	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1999	CHEMBL2111392	105087	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia	GABRB1
P18505	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB1
P18505	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB1
P18505	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB1
P18505	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB1
P18505	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D000437: Alcoholism	GABRB1
P18505	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
P18505	NA	NA	NA	NA	ZOLPIDEM TARTRATE	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2111392	105087	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity	GABRB1
P18505	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB1
P18505	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P18505	Gamma-aminobutyric acid receptor subunit beta-1	Homo sapiens	NA	GABRB1
Q14123	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE1C
Q14123	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE1C
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7
Q8IZS8	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA2D3
Q8IZS8	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA2D3
Q8IZS8	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNA2D3
Q8IZS8	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3
Q8IZS8	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3
Q8IZS8	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA2D3
P09237	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1967	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP7
P09237	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1974	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D010019: Osteomyelitis	MMP7
P09237	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1967	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP7
P56696	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P56696	Potassium voltage-gated channel subfamily KQT member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNQ4
P56696	NA	NA	NA	NA	EZOGABINE	KCNQ (Kv7) potassium channel blocker	BLOCKER	2011	CHEMBL2363063	105758	P56696	Potassium voltage-gated channel subfamily KQT member 4	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D006562: Herpes Zoster,D012640: Seizures	KCNQ4
P56696	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P56696	Potassium voltage-gated channel subfamily KQT member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNQ4
P56696	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P56696	Potassium voltage-gated channel subfamily KQT member 4	Homo sapiens	NA	KCNQ4
P56696	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P56696	Potassium voltage-gated channel subfamily KQT member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNQ4
P29320	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29320	Ephrin type-A receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA3
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1955	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC18A2
Q05940	NA	NA	NA	NA	RESERPINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis	SLC18A2
Q05940	NA	NA	NA	NA	TETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2008	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2
Q05940	NA	NA	NA	NA	RESCINNAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1956	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2
Q05940	NA	NA	NA	NA	DESERPIDINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1957	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1975	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2
Q05940	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2007	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC18A2
Q05940	NA	NA	NA	NA	VALBENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2
Q05940	NA	NA	NA	NA	DUTETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002547: Cerebral Palsy,D002819: Chorea,D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders,D020821: Dystonic Disorders	SLC18A2
Q05940	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2
Q05940	NA	NA	NA	NA	VALBENAZINE TOSYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D000071057: Tardive Dyskinesia	SLC18A2
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1996	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2
Q9Y3Q4	NA	NA	NA	NA	IVABRADINE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	2015	CHEMBL1250417	103531	Q9Y3Q4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens	D000072658: Non-ST Elevated Myocardial Infarction,D000375: Aging,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006333: Heart Failure,D007022: Hypotension,D007024: Hypotension, Orthostatic,D008223: Lymphoma,D008946: Mitral Valve Stenosis,D009102: Multiple Organ Failure,D009369: Neoplasms,D012772: Shock, Septic,D013610: Tachycardia,D054143: Heart Failure, Systolic,D054144: Heart Failure, Diastolic,D060050: Angina, Stable	HCN4
Q9Y3Q4	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	2009	CHEMBL1250417	103531	Q9Y3Q4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens	D001281: Atrial Fibrillation	HCN4
Q9Y3Q4	NA	NA	NA	NA	IVABRADINE HYDROCHLORIDE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	2015	CHEMBL1250417	103531	Q9Y3Q4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens	D006333: Heart Failure	HCN4
P40189	NA	NA	NA	NA	SATRALIZUMAB	IL6Ralpha/GP130 antagonist	ANTAGONIST	2020	CHEMBL3137266	108122	P40189	Interleukin-6 receptor subunit beta	Homo sapiens	D007154: Immune System Diseases,D009471: Neuromyelitis Optica	IL6ST
P08588	NA	NA	NA	NA	ATENOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1981	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D006331: Heart Diseases,D006333: Heart Failure,D006391: Hemangioma,D006973: Hypertension,D008382: Marfan Syndrome,D008946: Mitral Valve Stenosis,D009203: Myocardial Infarction,D010024: Osteoporosis,D013313: Stress Disorders, Post-Traumatic,D017202: Myocardial Ischemia,D017379: Hypertrophy, Left Ventricular,D060050: Angina, Stable	ADRB1
P08588	NA	NA	NA	NA	TIMOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB1
P08588	NA	NA	NA	NA	PINDOLOL	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB1
P08588	NA	NA	NA	NA	NADOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB1
P08588	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB1
P08588	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB1
P08588	NA	NA	NA	NA	DOPAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1974	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010300: Parkinson Disease	ADRB1
P08588	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB1
P08588	NA	NA	NA	NA	BETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ADRB1
P08588	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1
P08588	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB1
P08588	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB1
P08588	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	ACEBUTOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D006973: Hypertension	ADRB1
P08588	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	LEVOBETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2000	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D009798: Ocular Hypertension	ADRB1
P08588	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB1
P08588	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB1
P08588	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1
P08588	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB1
P08588	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB1
P08588	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB1
P08588	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1990	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB1
P08588	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB1
P08588	NA	NA	NA	NA	BISOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D020388: Muscular Dystrophy, Duchenne	ADRB1
P08588	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB1
P08588	NA	NA	NA	NA	METOPROLOL TARTRATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ADRB1
P08588	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB1
P08588	NA	NA	NA	NA	METOPROLOL SUCCINATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000787: Angina Pectoris,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008944: Mitral Valve Insufficiency,D029424: Pulmonary Disease, Chronic Obstructive	ADRB1
P08588	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
P08588	NA	NA	NA	NA	METOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1
Q00975	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1B
Q00975	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1B
Q00975	NA	NA	NA	NA	LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	1999	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001037: Aphasia,D001714: Bipolar Disorder,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D005909: Glioblastoma,D005910: Glioma,D006562: Herpes Zoster,D009069: Movement Disorders,D009293: Opioid-Related Disorders,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011115: Polyneuropathies,D011618: Psychotic Disorders,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D013375: Substance Withdrawal Syndrome,D014103: Torticollis,D015470: Leukemia, Myeloid, Acute,D016584: Panic Disorder,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020329: Essential Tremor,D020521: Stroke,D060825: Cognitive Dysfunction	CACNA1B
Q00975	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1B
Q00975	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	NA	CACNA1B
Q00975	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	NA	CACNA1B
Q00975	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1B
Q00975	NA	NA	NA	NA	ZICONOTIDE ACETATE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	2004	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D005334: Fever,D010146: Pain	CACNA1B
Q00975	NA	NA	NA	NA	ZICONOTIDE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	2004	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D005334: Fever,D010146: Pain	CACNA1B
P10275	NA	NA	NA	NA	BICALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1995	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D005185: Fallopian Tube Neoplasms,D006177: Gynecomastia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D011629: Puberty, Precocious,D012468: Salivary Gland Neoplasms,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	FLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1989	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	TESTOSTERONE PROPIONATE	Androgen Receptor agonist	AGONIST	1974	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D059268: Atrophic Vaginitis	AR
P10275	NA	NA	NA	NA	NILUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1996	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	METHYLTESTOSTERONE	Androgen Receptor agonist	AGONIST	1973	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008593: Menopause	AR
P10275	NA	NA	NA	NA	TESTOSTERONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000375: Aging,D000856: Anorexia Nervosa,D002539: Cerebral Arterial Diseases,D003327: Coronary Disease,D004392: Dwarfism,D004414: Dyspareunia,D006333: Heart Failure,D006620: Hip Fractures,D007006: Hypogonadism,D007172: Erectile Dysfunction,D007246: Infertility,D007333: Insulin Resistance,D007713: Klinefelter Syndrome,D008593: Menopause,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D009369: Neoplasms,D009765: Obesity,D009920: Orchitis,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D013736: Testicular Neoplasms,D017436: Kallmann Syndrome,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D055948: Sarcopenia,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	FLUOXYMESTERONE	Androgen Receptor agonist	AGONIST	1956	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms	AR
P10275	NA	NA	NA	NA	DANAZOL	Androgen Receptor agonist	AGONIST	1976	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	AR
P10275	NA	NA	NA	NA	ENZALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2012	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	TESTOSTERONE ENANTHATE	Androgen Receptor agonist	AGONIST	1953	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D007006: Hypogonadism,D011471: Prostatic Neoplasms,D015431: Weight Loss,D019247: HIV Wasting Syndrome,D020391: Muscular Dystrophy, Facioscapulohumeral,D029424: Pulmonary Disease, Chronic Obstructive,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	NANDROLONE PHENPROPIONATE	Androgen Receptor agonist	AGONIST	1959	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases	AR
P10275	NA	NA	NA	NA	OXANDROLONE	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D002056: Burns,D003668: Pressure Ulcer,D005199: Fanconi Anemia,D007713: Klinefelter Syndrome,D009369: Neoplasms,D014424: Turner Syndrome,D044342: Malnutrition	AR
P10275	NA	NA	NA	NA	OXYMETHOLONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR
P10275	NA	NA	NA	NA	ETHYLESTRENOL	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR
P10275	NA	NA	NA	NA	NANDROLONE DECANOATE	Androgen Receptor agonist	AGONIST	1983	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases,D006620: Hip Fractures,D019247: HIV Wasting Syndrome,D044342: Malnutrition	AR
P10275	NA	NA	NA	NA	DROMOSTANOLONE PROPIONATE	Androgen Receptor agonist	AGONIST	1982	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR
P10275	NA	NA	NA	NA	TESTOSTERONE CYPIONATE	Androgen Receptor agonist	AGONIST	1978	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D003929: Diabetic Neuropathies,D007006: Hypogonadism,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	STANOZOLOL	Androgen Receptor agonist	AGONIST	1962	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR
P10275	NA	NA	NA	NA	TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AGONIST	2014	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000375: Aging,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D007006: Hypogonadism,D012131: Respiratory Insufficiency,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D044342: Malnutrition	AR
P10275	NA	NA	NA	NA	APALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2018	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008107: Liver Diseases,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P10275	NA	NA	NA	NA	CLASCOTERONE	Androgen Receptor antagonist	ANTAGONIST	2020	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000152: Acne Vulgaris,D000505: Alopecia	AR
P10275	NA	NA	NA	NA	DAROLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2019	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR
P06401	NA	NA	NA	NA	PROGESTERONE	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D000568: Amenorrhea,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004714: Endometrial Hyperplasia,D004827: Epilepsy,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007247: Infertility, Female,D007724: Vulvar Lichen Sclerosus,D007889: Leiomyoma,D008569: Memory Disorders,D008593: Menopause,D010024: Osteoporosis,D010923: Placenta Previa,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011247: Pregnancy,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014592: Uterine Hemorrhage,D015658: HIV Infections,D016471: Ovarian Hyperstimulation Syndrome,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D018290: Cervical Intraepithelial Neoplasia,D019052: Depression, Postpartum,D019970: Cocaine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D052018: Bulimia Nervosa,D054971: Orthostatic Intolerance	PGR
P06401	NA	NA	NA	NA	MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	1959	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006331: Heart Diseases,D006470: Hemorrhage,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007680: Kidney Neoplasms,D008180: Lupus Erythematosus, Systemic,D008593: Menopause,D008595: Menorrhagia,D009369: Neoplasms,D010024: Osteoporosis,D010146: Pain,D011247: Pregnancy,D011471: Prostatic Neoplasms,D012891: Sleep Apnea Syndromes,D013927: Thrombosis,D014424: Turner Syndrome,D015658: HIV Infections,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes	PGR
P06401	NA	NA	NA	NA	NORETHINDRONE	Progesterone receptor agonist	AGONIST	1962	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D004412: Dysmenorrhea,D004715: Endometriosis,D006526: Hepatitis C,D008593: Menopause,D009369: Neoplasms,D010146: Pain,D012735: Sexual Dysfunction, Physiological,D015427: Reperfusion Injury,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	PGR
P06401	NA	NA	NA	NA	NORETHYNODREL	Progesterone receptor agonist	AGONIST	1961	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR
P06401	NA	NA	NA	NA	LEVONORGESTREL	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D008595: Menorrhagia,D008881: Migraine Disorders,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D062788: Adenomyosis	PGR
P06401	NA	NA	NA	NA	DANAZOL	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	PGR
P06401	NA	NA	NA	NA	DROSPIRENONE	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	PGR
P06401	NA	NA	NA	NA	ETONOGESTREL	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D004412: Dysmenorrhea,D011470: Prostatic Hyperplasia,D015658: HIV Infections	PGR
P06401	NA	NA	NA	NA	DESOGESTREL	Progesterone receptor agonist	AGONIST	1992	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000568: Amenorrhea,D006470: Hemorrhage,D011085: Polycystic Ovary Syndrome,D020182: Sleep Apnea, Central	PGR
P06401	NA	NA	NA	NA	ULIPRISTAL ACETATE	Progesterone receptor modulator	MODULATOR	2010	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D001943: Breast Neoplasms,D002607: Charcot-Marie-Tooth Disease,D003866: Depressive Disorder,D006470: Hemorrhage,D007889: Leiomyoma,D008593: Menopause,D011293: Premenstrual Syndrome,D062788: Adenomyosis	PGR
P06401	NA	NA	NA	NA	ETHYNODIOL DIACETATE	Progesterone receptor agonist	AGONIST	1966	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR
P06401	NA	NA	NA	NA	NORELGESTROMIN	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D008796: Metrorrhagia,D011247: Pregnancy,D015658: HIV Infections	PGR
P06401	NA	NA	NA	NA	HYDROXYPROGESTERONE CAPROATE	Progesterone receptor agonist	AGONIST	1975	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D011247: Pregnancy,D047928: Premature Birth	PGR
P06401	NA	NA	NA	NA	DYDROGESTERONE	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000026: Abortion, Habitual,D004714: Endometrial Hyperplasia,D007246: Infertility,D007247: Infertility, Female,D008593: Menopause,D010048: Ovarian Cysts,D011247: Pregnancy,D047928: Premature Birth	PGR
P06401	NA	NA	NA	NA	NORGESTIMATE	Progesterone receptor agonist	AGONIST	1989	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D003550: Cystic Fibrosis,D006526: Hepatitis C,D008796: Metrorrhagia,D008881: Migraine Disorders,D009436: Neural Tube Defects,D010024: Osteoporosis,D015658: HIV Infections	PGR
P06401	NA	NA	NA	NA	MEGESTROL ACETATE	Progesterone receptor agonist	AGONIST	1971	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000855: Anorexia,D001943: Breast Neoplasms,D002100: Cachexia,D002278: Carcinoma in Situ,D003704: Dementia,D004714: Endometrial Hyperplasia,D006258: Head and Neck Neoplasms,D008113: Liver Neoplasms,D009369: Neoplasms,D014594: Uterine Neoplasms,D016889: Endometrial Neoplasms,D019247: HIV Wasting Syndrome,D019584: Hot Flashes,D029424: Pulmonary Disease, Chronic Obstructive	PGR
P06401	NA	NA	NA	NA	NORETHINDRONE ACETATE	Progesterone receptor agonist	AGONIST	1973	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D001943: Breast Neoplasms,D003550: Cystic Fibrosis,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D007006: Hypogonadism,D007889: Leiomyoma,D008223: Lymphoma,D010146: Pain,D011247: Pregnancy,D016649: Primary Ovarian Insufficiency	PGR
P06401	NA	NA	NA	NA	MIFEPRISTONE	Progesterone receptor antagonist	ANTAGONIST	2000	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000022: Abortion, Spontaneous,D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D003480: Cushing Syndrome,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D004715: Endometriosis,D005185: Fallopian Tube Neoplasms,D006526: Hepatitis C,D007889: Leiomyoma,D008579: Meningioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015658: HIV Infections,D016889: Endometrial Neoplasms,D018567: Breast Neoplasms, Male,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D047748: Pituitary ACTH Hypersecretion,D056833: Central Serous Chorioretinopathy,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PGR
P06401	NA	NA	NA	NA	NORGESTREL	Progesterone receptor agonist	AGONIST	1968	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D016889: Endometrial Neoplasms	PGR
P06401	NA	NA	NA	NA	SEGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	2018	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR
P49763	NA	NA	NA	NA	AFLIBERCEPT	Placenta growth factor inhibitor	INHIBITOR	2011	CHEMBL1697671	103950	P49763	Placenta growth factor	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003930: Diabetic Retinopathy,D005901: Glaucoma,D005910: Glioma,D006660: Histoplasmosis,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D008269: Macular Edema,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D011561: Pseudoxanthoma Elasticum,D012004: Rectal Neoplasms,D012164: Retinal Diseases,D012170: Retinal Vein Occlusion,D012178: Retinopathy of Prematurity,D013684: Telangiectasis,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014823: Vitreous Hemorrhage,D015179: Colorectal Neoplasms,D015355: Glaucoma, Neovascular,D015861: Retinal Neovascularization,D016510: Corneal Neovascularization,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D047728: Myopia, Degenerative,D049970: Graves Ophthalmopathy,D055752: Small Cell Lung Carcinoma,D056833: Central Serous Chorioretinopathy,D057135: Wet Macular Degeneration	PGF
O15554	NA	NA	NA	NA	CHLORZOXAZONE	Intermediate conductance calcium-activated potassium channel protein 4 opener	OPENER	1958	CHEMBL4305	10992	O15554	Intermediate conductance calcium-activated potassium channel protein 4	Homo sapiens	NA	KCNN4
P19971	NA	NA	NA	NA	TIPIRACIL HYDROCHLORIDE	Thymidine phosphorylase inhibitor	INHIBITOR	2015	CHEMBL3106	11723	P19971	Thymidine phosphorylase	Homo sapiens	D012004: Rectal Neoplasms,D015179: Colorectal Neoplasms	TYMP
P09758	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	Tumor-associated calcium signal transducer 2 binding agent	BINDING AGENT	2020	CHEMBL3856163	116939	P09758	Tumor-associated calcium signal transducer 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TACSTD2
P08631	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	INHIBITOR	2010	CHEMBL3234	11785	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	HCK
P08631	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HCK
Q07343	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE4B
Q07343	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE4B
Q07343	NA	NA	NA	NA	AMLEXANOX	Phosphodiesterase 4 inhibitor	INHIBITOR	1996	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive,D013280: Stomatitis	PDE4B
Q07343	NA	NA	NA	NA	ROFLUMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2011	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D001249: Asthma,D001987: Bronchiectasis,D003704: Dementia,D003865: Depressive Disorder, Major,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D008173: Lung Diseases, Obstructive,D008223: Lymphoma,D009369: Neoplasms,D009422: Nervous System Diseases,D009765: Obesity,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	PDE4B
Q07343	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE4B
Q07343	NA	NA	NA	NA	APREMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2014	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000152: Acne Vulgaris,D000437: Alcoholism,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003093: Colitis, Ulcerative,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004485: Eczema,D006073: Gout,D007154: Immune System Diseases,D008010: Lichen Planus,D008179: Lupus Erythematosus, Discoid,D011472: Prostatitis,D011565: Psoriasis,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013281: Stomatitis, Aphthous,D014605: Uveitis,D014820: Vitiligo,D015535: Arthritis, Psoriatic,D017449: Dermatitis, Allergic Contact,D017497: Hidradenitis Suppurativa,D017676: Lichen Planus, Oral,D045169: Severe Acute Respiratory Syndrome	PDE4B
Q07343	NA	NA	NA	NA	CRISABOROLE	Phosphodiesterase 4 inhibitor	INHIBITOR	2016	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000506: Alopecia Areata,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D012594: Scleroderma, Localized	PDE4B
Q07343	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1951	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4B
Q07343	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1981	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4B
Q07343	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 4 inhibitor	INHIBITOR	1982	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	NA	PDE4B
Q07343	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 4 inhibitor	INHIBITOR	1970	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	NA	PDE4B
Q07343	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE4B
P51679	NA	NA	NA	NA	MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CROSS-LINKING AGENT	2018	CHEMBL2414	10579	P51679	C-C chemokine receptor type 4	Homo sapiens	D001249: Asthma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D015493: Paraparesis, Tropical Spastic,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral	CCR4
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1
P51665	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P51665	26S proteasome non-ATPase regulatory subunit 7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD7
P51665	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P51665	26S proteasome non-ATPase regulatory subunit 7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD7
P51665	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P51665	26S proteasome non-ATPase regulatory subunit 7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD7
P40306	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P40306	Proteasome subunit beta type-10	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB10
P40306	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P40306	Proteasome subunit beta type-10	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB10
P40306	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P40306	Proteasome subunit beta type-10	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB10
Q9H2M3	NA	NA	NA	NA	BETAINE	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	1996	CHEMBL3391661	109554	Q9H2M3	S-methylmethionine--homocysteine S-methyltransferase BHMT2	Homo sapiens	D003866: Depressive Disorder,D006526: Hepatitis C,D006712: Homocystinuria,D006960: Hyperoxaluria, Primary,D007248: Infertility, Male,D009765: Obesity,D019698: Hepatitis C, Chronic,D065626: Non-alcoholic Fatty Liver Disease	BHMT2
Q96RI1	NA	NA	NA	NA	CHENODIOL	Bile acid receptor FXR agonist	AGONIST	1983	CHEMBL2047	11180	Q96RI1	Bile acid receptor	Homo sapiens	D010264: Paraplegia,D019294: Xanthomatosis, Cerebrotendinous,D043183: Irritable Bowel Syndrome	NR1H4
Q96RI1	NA	NA	NA	NA	URSODIOL	Bile acid receptor FXR agonist	AGONIST	1987	CHEMBL2047	11180	Q96RI1	Bile acid receptor	Homo sapiens	D002769: Cholelithiasis,D002779: Cholestasis,D002780: Cholestasis, Intrahepatic,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006816: Huntington Disease,D007249: Inflammation,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008107: Liver Diseases,D009765: Obesity,D010300: Parkinson Disease,D011125: Adenomatous Polyposis Coli,D011247: Pregnancy,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D018149: Glucose Intolerance,D019698: Hepatitis C, Chronic,D041781: Jaundice, Obstructive,D056486: Chemical and Drug Induced Liver Injury,D065626: Non-alcoholic Fatty Liver Disease	NR1H4
Q96RI1	NA	NA	NA	NA	OBETICHOLIC ACID	Bile acid receptor FXR agonist	AGONIST	2016	CHEMBL2047	11180	Q96RI1	Bile acid receptor	Homo sapiens	D002779: Cholestasis,D003967: Diarrhea,D006519: Hepatitis, Alcoholic,D008105: Liver Cirrhosis, Biliary,D008107: Liver Diseases,D009765: Obesity,D052496: Lipodystrophy, Familial Partial,D065626: Non-alcoholic Fatty Liver Disease	NR1H4
Q16552	NA	NA	NA	NA	IXEKIZUMAB	Interleukin 17A inhibitor	INHIBITOR	2016	CHEMBL3390822	109547	Q16552	Interleukin-17A	Homo sapiens	D001172: Arthritis, Rheumatoid,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D010391: Pemphigoid, Bullous,D011565: Psoriasis,D011711: Pyoderma,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D045169: Severe Acute Respiratory Syndrome	IL17A
Q16552	NA	NA	NA	NA	SECUKINUMAB	Interleukin 17A inhibitor	INHIBITOR	2015	CHEMBL3390822	109547	Q16552	Interleukin-17A	Homo sapiens	D000506: Alopecia Areata,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001528: Behcet Syndrome,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D008179: Lupus Erythematosus, Discoid,D008181: Lupus Nephritis,D009103: Multiple Sclerosis,D009335: Necrobiosis Lipoidica,D010003: Osteoarthritis,D011111: Polymyalgia Rheumatica,D011565: Psoriasis,D011711: Pyoderma,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D015352: Dry Eye Syndromes,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D020529: Multiple Sclerosis, Relapsing-Remitting,D025242: Spondylarthropathies,D049970: Graves Ophthalmopathy,D052256: Tendinopathy	IL17A
P09884	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLA1
P09884	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLA1
P09884	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLA1
P09884	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLA1
P25103	NA	NA	NA	NA	NETUPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2014	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D009369: Neoplasms,D020250: Postoperative Nausea and Vomiting	TACR1
P25103	NA	NA	NA	NA	APREPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2003	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D000437: Alcoholism,D002189: Marijuana Abuse,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D005909: Glioblastoma,D006556: Heroin Dependence,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009325: Nausea,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010146: Pain,D011537: Pruritus,D014839: Vomiting,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018589: Gastroparesis,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D045169: Severe Acute Respiratory Syndrome	TACR1
P25103	NA	NA	NA	NA	FOSAPREPITANT DIMEGLUMINE	Neurokinin 1 receptor antagonist	ANTAGONIST	2008	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1
P25103	NA	NA	NA	NA	ROLAPITANT HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2015	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1
P25103	NA	NA	NA	NA	FOSNETUPITANT CHLORIDE HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2018	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D014839: Vomiting	TACR1
P48169	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA4
P48169	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA4
P48169	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA4
P48169	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy	GABRA4
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA4
P48169	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA4
P48169	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D008881: Migraine Disorders	GABRA4
P48169	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA4
P48169	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA4
P48169	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA4
P48169	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA4
P48169	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA4
P48169	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA4
P48169	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA4
P48169	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia	GABRA4
P48169	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA4
P48169	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA4
P48169	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA4
P48169	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4
P48169	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4
P48169	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4
P48169	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA4
P48169	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA4
P48169	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA4
P48169	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA4
P48169	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA4
P48169	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA4
P48169	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA4
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA4
P48169	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism	GABRA4
P48169	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
P48169	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA4
P48169	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4
Q9UBN1	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG4
Q9UBN1	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG4
Q9UBN1	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG4
Q9UBN1	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4
Q9UBN1	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4
Q9UBN1	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG4
P06276	NA	NA	NA	NA	RIVASTIGMINE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	2000	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	D000544: Alzheimer Disease,D001007: Anxiety,D001930: Brain Injuries,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D004314: Down Syndrome,D010300: Parkinson Disease,D012559: Schizophrenia,D013494: Supranuclear Palsy, Progressive,D015140: Dementia, Vascular,D019954: Neurobehavioral Manifestations,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D060825: Cognitive Dysfunction	BCHE
P06276	NA	NA	NA	NA	RIVASTIGMINE TARTRATE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	2000	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	D003704: Dementia,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease	BCHE
P06276	NA	NA	NA	NA	TACRINE HYDROCHLORIDE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	1993	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	NA	BCHE
Q05586	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN1
Q05586	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN1
Q05586	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN1
Q05586	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN1
Q05586	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN1
Q05586	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D010146: Pain	GRIN1
Q05586	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D010300: Parkinson Disease	GRIN1
Q05586	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000437: Alcoholism	GRIN1
Q05586	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN1
P68371	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4B
P68371	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB4B
P68371	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4B
P68371	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB4B
P68371	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB4B
P68371	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB4B
P68371	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4B
P68371	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB4B
P68371	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P68371	Tubulin beta-4B chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB4B
Q9NSA0	NA	NA	NA	NA	PROBENECID	Solute carrier family 22 member 11 inhibitor	INHIBITOR	1951	CHEMBL2073677	104618	Q9NSA0	Solute carrier family 22 member 11	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D002481: Cellulitis,D002805: Chondrocalcinosis,D003924: Diabetes Mellitus, Type 2,D005585: Influenza in Birds,D006073: Gout,D006333: Heart Failure,D007239: Infections,D009369: Neoplasms,D009765: Obesity,D014552: Urinary Tract Infections,D054143: Heart Failure, Systolic	SLC22A11
P30874	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P30874	Somatostatin receptor type 2	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR2
P30874	NA	NA	NA	NA	LANREOTIDE ACETATE	Somatostatin receptor 2 agonist	AGONIST	2007	CHEMBL1804	117	P30874	Somatostatin receptor type 2	Homo sapiens	D000172: Acromegaly,D002276: Carcinoid Tumor	SSTR2
P30874	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 2 agonist	AGONIST	2012	CHEMBL1804	117	P30874	Somatostatin receptor type 2	Homo sapiens	NA	SSTR2
P30874	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 2 agonist	AGONIST	2014	CHEMBL1804	117	P30874	Somatostatin receptor type 2	Homo sapiens	D000172: Acromegaly	SSTR2
P30874	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P30874	Somatostatin receptor type 2	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR2
Q969P6	NA	NA	NA	NA	TOPOTECAN HYDROCHLORIDE	DNA topoisomerase I, mitochondrial inhibitor	INHIBITOR	1996	CHEMBL2362989	105701	Q969P6	DNA topoisomerase I, mitochondrial	Homo sapiens	D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008479: Mediastinal Neoplasms,D008545: Melanoma,D008577: Meningeal Neoplasms,D008582: Meningitis, Aseptic,D008637: Mesenchymoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018269: Carcinoma, Endometrioid,D018288: Carcinoma, Small Cell,D018293: Cystadenoma, Serous,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP1MT
P20618	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB1
P20618	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB1
P20618	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB1
P54709	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1B3
P54709	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1B3
P54709	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1B3
P54709	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1B3
P13637	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A3
P13637	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3
P13637	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A3
P13637	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3
P02671	NA	NA	NA	NA	FIBRINOLYSIN, HUMAN	Fibrinogen inhibitor	INHIBITOR	1964	CHEMBL2364709	106205	P02671	Fibrinogen alpha chain	Homo sapiens	D000083242: Ischemic Stroke,D013927: Thrombosis	FGA
P00374	NA	NA	NA	NA	METHOTREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000506: Alopecia Areata,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D002583: Uterine Cervical Neoplasms,D002822: Choriocarcinoma,D003093: Colitis, Ulcerative,D003251: Constriction, Pathologic,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006319: Hearing Loss, Sensorineural,D006457: Hemoglobinuria, Paroxysmal,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006828: Hydatidiform Mole,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007249: Inflammation,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008269: Macular Edema,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010003: Osteoarthritis,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010391: Pemphigoid, Bullous,D011087: Polycythemia Vera,D011271: Pregnancy, Ectopic,D011565: Psoriasis,D012507: Sarcoidosis,D012509: Sarcoma,D012516: Osteosarcoma,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014523: Urethral Neoplasms,D014581: Urticaria,D014605: Uveitis,D014657: Vasculitis,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018242: Neuroectodermal Tumors, Primitive,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D056833: Central Serous Chorioretinopathy	DHFR
P00374	NA	NA	NA	NA	PRALATREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	2009	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic	DHFR
P00374	NA	NA	NA	NA	PEMETREXED DISODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	2004	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018287: Carcinoma, Large Cell,D031901: Gestational Trophoblastic Disease,D064129: Prostatic Neoplasms, Castration-Resistant	DHFR
P00374	NA	NA	NA	NA	METHOTREXATE SODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR
P14867	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA1
P14867	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA1
P14867	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA1
P14867	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy	GABRA1
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA1
P14867	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA1
P14867	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D008881: Migraine Disorders	GABRA1
P14867	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA1
P14867	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA1
P14867	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA1
P14867	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA1
P14867	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA1
P14867	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA1
P14867	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA1
P14867	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia	GABRA1
P14867	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA1
P14867	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA1
P14867	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA1
P14867	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1
P14867	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1
P14867	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1
P14867	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA1
P14867	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA1
P14867	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA1
P14867	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA1
P14867	NA	NA	NA	NA	ZALEPLON	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1999	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia	GABRA1
P14867	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA1
P14867	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA1
P14867	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA1
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA1
P14867	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism	GABRA1
P14867	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P14867	NA	NA	NA	NA	ZOLPIDEM TARTRATE	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity	GABRA1
P14867	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA1
P14867	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1
P12107	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL11A1
P12107	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL11A1
P57789	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 10 opener	OPENER	1958	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	NA	KCNK10
P57789	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1979	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK10
P57789	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1972	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	NA	KCNK10
P57789	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1995	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK10
P57789	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1992	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK10
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4
P03952	NA	NA	NA	NA	APROTININ	Plasma kallikrein inhibitor	INHIBITOR	1993	CHEMBL2000	23	P03952	Plasma kallikrein	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	KLKB1
P03952	NA	NA	NA	NA	ECALLANTIDE	Plasma kallikrein inhibitor	INHIBITOR	2009	CHEMBL2000	23	P03952	Plasma kallikrein	Homo sapiens	D000799: Angioedema,D054179: Angioedemas, Hereditary	KLKB1
P03952	NA	NA	NA	NA	LANADELUMAB	Plasma kallikrein inhibitor	INHIBITOR	2018	CHEMBL2000	23	P03952	Plasma kallikrein	Homo sapiens	D000799: Angioedema,D045169: Severe Acute Respiratory Syndrome,D054179: Angioedemas, Hereditary	KLKB1
P03952	NA	NA	NA	NA	BEROTRALSTAT HYDROCHLORIDE	Plasma kallikrein inhibitor	INHIBITOR	2020	CHEMBL2000	23	P03952	Plasma kallikrein	Homo sapiens	D054179: Angioedemas, Hereditary	KLKB1
P21728	NA	NA	NA	NA	FENOLDOPAM MESYLATE	Dopamine D1 receptor agonist	AGONIST	1997	CHEMBL2056	88	P21728	D(1A) dopamine receptor	Homo sapiens	D058186: Acute Kidney Injury	DRD1
P21728	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD1
P21728	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	NA	DRD1
P21728	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD1
P21728	NA	NA	NA	NA	METHYLERGONOVINE MALEATE	Dopamine D1 receptor antagonist	ANTAGONIST	1946	CHEMBL2056	88	P21728	D(1A) dopamine receptor	Homo sapiens	D006470: Hemorrhage	DRD1
P21728	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD1
Q09470	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA1
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA1
Q09470	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	NA	KCNA1
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA1
Q9UGN5	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2
Q9UGN5	NA	NA	NA	NA	NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012512: Sarcoma, Ewing,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2
Q9UGN5	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute,D064726: Triple Negative Breast Neoplasms	PARP2
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006394: Hemangiosarcoma,D007938: Leukemia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2
Q9UGN5	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP2
Q9UGN5	NA	NA	NA	NA	NIRAPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	PARP2
P15056	NA	NA	NA	NA	SORAFENIB TOSYLATE	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	2005	CHEMBL5145	100126	P15056	Serine/threonine-protein kinase B-raf	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	BRAF
P15056	NA	NA	NA	NA	VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	2011	CHEMBL5145	100126	P15056	Serine/threonine-protein kinase B-raf	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D003397: Craniopharyngioma,D005910: Glioma,D006646: Histiocytosis, Langerhans-Cell,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute	BRAF
P15056	NA	NA	NA	NA	REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	2012	CHEMBL5145	100126	P15056	Serine/threonine-protein kinase B-raf	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	BRAF
P15056	NA	NA	NA	NA	DABRAFENIB MESYLATE	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	2013	CHEMBL5145	100126	P15056	Serine/threonine-protein kinase B-raf	Homo sapiens	D008545: Melanoma,D009101: Multiple Myeloma,D013964: Thyroid Neoplasms,D031249: Erdheim-Chester Disease	BRAF
P15056	NA	NA	NA	NA	ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	2018	CHEMBL5145	100126	P15056	Serine/threonine-protein kinase B-raf	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D007943: Leukemia, Hairy Cell,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms	BRAF
P41145	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRK1
P41145	NA	NA	NA	NA	BUTORPHANOL TARTRATE	Kappa opioid receptor partial agonist	PARTIAL AGONIST	1978	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1
P41145	NA	NA	NA	NA	BUPRENORPHINE	Kappa opioid receptor agonist	AGONIST	1981	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000755: Anemia, Sickle Cell,D001416: Back Pain,D002294: Carcinoma, Squamous Cell,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006526: Hepatitis C,D006556: Heroin Dependence,D009021: Morphine Dependence,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D013375: Substance Withdrawal Syndrome,D014098: Toothache,D015658: HIV Infections,D017116: Low Back Pain,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain,D059787: Acute Pain	OPRK1
P41145	NA	NA	NA	NA	DEZOCINE	Kappa opioid receptor antagonist	ANTAGONIST	1989	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain	OPRK1
P41145	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRK1
P41145	NA	NA	NA	NA	ANILERIDINE PHOSPHATE	Kappa opioid receptor agonist	AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1
P41145	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRK1
P41145	NA	NA	NA	NA	ANILERIDINE HYDROCHLORIDE	Kappa opioid receptor agonist	AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1
P41145	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRK1
P41145	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRK1
P41145	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRK1
P41145	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRK1
P41145	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003371: Cough	OPRK1
P41145	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1
P41145	NA	NA	NA	NA	LEVALLORPHAN TARTRATE	Kappa opioid receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1
P41145	NA	NA	NA	NA	BUPRENORPHINE HYDROCHLORIDE	Kappa opioid receptor agonist	AGONIST	1981	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D009293: Opioid-Related Disorders,D019966: Substance-Related Disorders	OPRK1
P41145	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRK1
P41145	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRK1
P41145	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain	OPRK1
O14561	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O14561	Acyl carrier protein, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAB1
P61073	NA	NA	NA	NA	PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	PARTIAL AGONIST	2008	CHEMBL2107	10473	P61073	C-X-C chemokine receptor type 4	Homo sapiens	D000755: Anemia, Sickle Cell,D003922: Diabetes Mellitus, Type 1,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008231: Lymphopenia,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009503: Neutropenia,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012595: Scleroderma, Systemic,D013789: Thalassemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058625: End Stage Liver Disease	CXCR4
O43497	NA	NA	NA	NA	TRIMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1946	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G
O43497	NA	NA	NA	NA	ETHOSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1960	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D003866: Depressive Disorder,D004827: Epilepsy,D004832: Epilepsy, Absence,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome	CACNA1G
O43497	NA	NA	NA	NA	METHSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1957	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G
O43497	NA	NA	NA	NA	PHENSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1982	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G
O43497	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1G
O43497	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1G
O43497	NA	NA	NA	NA	PARAMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1949	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G
O43497	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1G
O43497	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G
O43497	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G
O43497	NA	NA	NA	NA	MIBEFRADIL DIHYDROCHLORIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1997	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G
O43497	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1G
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Sigma opioid receptor agonist	AGONIST	1982	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D002659: Child Development Disorders, Pervasive	SIGMAR1
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Sigma opioid receptor agonist	AGONIST	1984	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	SIGMAR1
Q99720	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Sigma opioid receptor antagonist	ANTAGONIST	2020	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	SIGMAR1
Q99720	NA	NA	NA	NA	PENTAZOCINE LACTATE	Sigma opioid receptor modulator	MODULATOR	1967	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	NA	SIGMAR1
Q99720	NA	NA	NA	NA	PENTAZOCINE HYDROCHLORIDE	Sigma opioid receptor modulator	MODULATOR	1969	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D010146: Pain	SIGMAR1
Q15858	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN9A
Q15858	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN9A
Q15858	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN9A
Q15858	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A
Q15858	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN9A
Q15858	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN9A
Q15858	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN9A
Q15858	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN9A
Q15858	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN9A
Q15858	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A
Q15858	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A
Q15858	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN9A
Q15858	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN9A
Q15858	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN9A
Q15858	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN9A
Q15858	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A
Q15858	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN9A
Q15858	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN9A
Q15858	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010146: Pain	SCN9A
Q15858	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN9A
Q15858	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN9A
Q15858	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN9A
Q15858	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A
Q15858	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN9A
Q15858	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN9A
Q15858	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A
Q15858	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN9A
Q15858	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN9A
Q15858	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN9A
Q15858	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN9A
Q15858	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN9A
Q15858	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A
Q15858	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN9A
Q15858	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN9A
P42261	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P42261	Glutamate receptor 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA1
P42261	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P42261	Glutamate receptor 1	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA1
P10253	NA	NA	NA	NA	MIGLITOL	Lysosomal alpha-glucosidase inhibitor	INHIBITOR	1996	CHEMBL2608	10977	P10253	Lysosomal alpha-glucosidase	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2	GAA
P05556	NA	NA	NA	NA	NATALIZUMAB	Integrin alpha-4/beta-1 inhibitor	INHIBITOR	2004	CHEMBL1907599	104293	P05556	Integrin beta-1	Homo sapiens	D000083242: Ischemic Stroke,D001172: Arthritis, Rheumatoid,D003424: Crohn Disease,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D012516: Osteosarcoma,D012559: Schizophrenia,D018979: Myositis, Inclusion Body,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	ITGB1
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG
P37288	NA	NA	NA	NA	VASOPRESSIN	Vasopressin receptor agonist	AGONIST	2014	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D001321: Autistic Disorder,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003919: Diabetes Insipidus,D006323: Heart Arrest,D006331: Heart Diseases,D006976: Hypertension, Pulmonary,D007022: Hypotension,D007889: Leiomyoma,D009214: Myoma,D010146: Pain,D010996: Pleural Effusion,D012769: Shock,D012772: Shock, Septic,D016757: Death, Sudden, Cardiac,D018805: Sepsis,D055371: Acute Lung Injury,D065630: Hernias, Diaphragmatic, Congenital	AVPR1A
P37288	NA	NA	NA	NA	DESMOPRESSIN ACETATE	Vasopressin receptor agonist	AGONIST	1978	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D006470: Hemorrhage,D006973: Hypertension,D011183: Postoperative Complications	AVPR1A
P37288	NA	NA	NA	NA	LYPRESSIN	Vasopressin receptor agonist	AGONIST	1982	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A
P37288	NA	NA	NA	NA	CONIVAPTAN HYDROCHLORIDE	Vasopressin V1a receptor antagonist	ANTAGONIST	2005	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	D007010: Hyponatremia,D008107: Liver Diseases	AVPR1A
P37288	NA	NA	NA	NA	VASOPRESSIN TANNATE	Vasopressin V1a receptor agonist	AGONIST	1982	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A
P54753	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54753	Ephrin type-B receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB3
P07942	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P07942	Laminin subunit beta-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB1
P34981	NA	NA	NA	NA	PROTIRELIN	Thyrotropin-releasing hormone receptor agonist	AGONIST	1976	CHEMBL1810	260	P34981	Thyrotropin-releasing hormone receptor	Homo sapiens	D009369: Neoplasms,D012128: Respiratory Distress Syndrome	TRHR
O75438	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O75438	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB1
Q9NPC2	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 9 opener	OPENER	1958	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	NA	KCNK9
Q9NPC2	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1979	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK9
Q9NPC2	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1972	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	NA	KCNK9
Q9NPC2	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1995	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK9
Q9NPC2	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1992	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK9
Q9NPC2	NA	NA	NA	NA	DOXAPRAM HYDROCHLORIDE	Potassium channel subfamily K member 9 blocker	BLOCKER	1965	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D016584: Panic Disorder	KCNK9
Q96PR1	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q96PR1	Potassium voltage-gated channel subfamily C member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNC2
Q96PR1	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q96PR1	Potassium voltage-gated channel subfamily C member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNC2
Q96PR1	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q96PR1	Potassium voltage-gated channel subfamily C member 2	Homo sapiens	NA	KCNC2
Q96PR1	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q96PR1	Potassium voltage-gated channel subfamily C member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNC2
P20839	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH1
P20839	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH1
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH1
P20839	NA	NA	NA	NA	RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	INHIBITOR	1985	CHEMBL1822	84	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D001943: Breast Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D004672: Encephalitis, Japanese,D005355: Fibrosis,D006480: Hemorrhagic Fever with Renal Syndrome,D006505: Hepatitis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D008103: Liver Cirrhosis,D009369: Neoplasms,D013921: Thrombocytopenia,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018357: Respiratory Syncytial Virus Infections,D019142: Hemorrhagic Fever, Ebola,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome	IMPDH1
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	NA	IMPDH1
Q01726	NA	NA	NA	NA	AFAMELANOTIDE	Melanocortin receptor 1 agonist	AGONIST	2019	CHEMBL3795	11869	Q01726	Melanocyte-stimulating hormone receptor	Homo sapiens	D014581: Urticaria,D014820: Vitiligo,D046351: Protoporphyria, Erythropoietic	MC1R
P09619	NA	NA	NA	NA	DASATINIB	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2006	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB
P09619	NA	NA	NA	NA	SUNITINIB MALATE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB
P09619	NA	NA	NA	NA	IMATINIB MESYLATE	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2001	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB
P09619	NA	NA	NA	NA	MIDOSTAURIN	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2017	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PDGFRB
P09619	NA	NA	NA	NA	SORAFENIB TOSYLATE	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2005	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB
P09619	NA	NA	NA	NA	BECAPLERMIN	Platelet-derived growth factor receptor agonist	AGONIST	1997	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D012883: Skin Ulcer,D014456: Ulcer,D017719: Diabetic Foot	PDGFRB
P09619	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB
P09619	NA	NA	NA	NA	REGORAFENIB	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	PDGFRB
P09619	NA	NA	NA	NA	NINTEDANIB ESYLATE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	NA	PDGFRB
P48039	NA	NA	NA	NA	RAMELTEON	Melatonin receptor agonist	AGONIST	2005	CHEMBL2094268	104733	P48039	Melatonin receptor type 1A	Homo sapiens	D001714: Bipolar Disorder,D002056: Burns,D002189: Marijuana Abuse,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019966: Substance-Related Disorders,D020181: Sleep Apnea, Obstructive,D020325: Migraine with Aura,D020326: Migraine without Aura,D029424: Pulmonary Disease, Chronic Obstructive	MTNR1A
P48039	NA	NA	NA	NA	TASIMELTEON	Melatonin receptor agonist	AGONIST	2014	CHEMBL2094268	104733	P48039	Melatonin receptor type 1A	Homo sapiens	D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D012893: Sleep Wake Disorders,D020178: Sleep Disorders, Circadian Rhythm,D058496: Smith-Magenis Syndrome	MTNR1A
P55017	NA	NA	NA	NA	INDAPAMIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1983	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D006973: Hypertension,D007669: Kidney Calculi	SLC12A3
P55017	CHEMBL3727515	2045238	NA	NA	HYDROCHLOROTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1959	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004487: Edema,D005921: Glomerulonephritis,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007669: Kidney Calculi,D007674: Kidney Diseases,D007676: Kidney Failure, Chronic,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008103: Liver Cirrhosis,D009203: Myocardial Infarction,D009404: Nephrotic Syndrome,D011225: Pre-Eclampsia,D016757: Death, Sudden, Cardiac,D024821: Metabolic Syndrome,D050197: Atherosclerosis	SLC12A3
P55017	NA	NA	NA	NA	CHLOROTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1958	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D009404: Nephrotic Syndrome,D050197: Atherosclerosis	SLC12A3
P55017	NA	NA	NA	NA	METOLAZONE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1973	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases,D006333: Heart Failure,D051436: Renal Insufficiency, Chronic	SLC12A3
P55017	NA	NA	NA	NA	CYCLOTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1982	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	TRICHLORMETHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1960	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	CHLORTHALIDONE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1960	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007676: Kidney Failure, Chronic,D009203: Myocardial Infarction,D016757: Death, Sudden, Cardiac,D017202: Myocardial Ischemia,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	SLC12A3
P55017	NA	NA	NA	NA	QUINETHAZONE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1963	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	METHYCLOTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1960	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	POLYTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1961	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	BENDROFLUMETHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1959	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension	SLC12A3
P55017	NA	NA	NA	NA	HYDROFLUMETHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1959	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	D002318: Cardiovascular Diseases	SLC12A3
P55017	NA	NA	NA	NA	CHLOROTHIAZIDE SODIUM	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1958	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	NA	SLC12A3
P55017	NA	NA	NA	NA	BENZTHIAZIDE	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	1960	CHEMBL1876	151	P55017	Solute carrier family 12 member 3	Homo sapiens	NA	SLC12A3
P25787	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA2
P25787	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA2
P25787	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA2
Q92731	NA	NA	NA	NA	RALOXIFENE HYDROCHLORIDE	Estrogen receptor beta modulator	MODULATOR	1997	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D011471: Prostatic Neoplasms	ESR2
Q92731	NA	NA	NA	NA	FULVESTRANT	Estrogen receptor antagonist	ANTAGONIST	2002	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005359: Fibrous Dysplasia, Polyostotic,D005833: Genital Neoplasms, Female,D006976: Hypertension, Pulmonary,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018203: Sarcoma, Endometrial Stromal,D018275: Carcinoma, Lobular,D044584: Carcinoma, Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2
Q92731	NA	NA	NA	NA	DIETHYLSTILBESTROL DIPHOSPHATE	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D009369: Neoplasms	ESR2
Q92731	NA	NA	NA	NA	TOREMIFENE CITRATE	Estrogen receptor modulator	MODULATOR	1997	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D010024: Osteoporosis,D050723: Fractures, Bone	ESR2
Q92731	NA	NA	NA	NA	ESTRAMUSTINE PHOSPHATE SODIUM	Estrogen receptor beta modulator	MODULATOR	1981	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D007680: Kidney Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2
Q92731	NA	NA	NA	NA	CHLOROTRIANISENE	Estrogen receptor beta modulator	MODULATOR	1982	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D006528: Carcinoma, Hepatocellular,D008113: Liver Neoplasms	ESR2
Q92731	NA	NA	NA	NA	QUINESTROL	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED SYNTHETIC A	Estrogen receptor agonist	AGONIST	1999	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2
Q92731	NA	NA	NA	NA	ESTROGENS, ESTERIFIED	Estrogen receptor agonist	AGONIST	1977	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause	ESR2
Q92731	NA	NA	NA	NA	SYNTHETIC CONJUGATED ESTROGENS, B	Estrogen receptor agonist	AGONIST	2004	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause	ESR2
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED	Estrogen receptor agonist	AGONIST	1942	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D000544: Alzheimer Disease,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D003110: Colonic Neoplasms,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D006937: Hypercholesterolemia,D006973: Hypertension,D008180: Lupus Erythematosus, Systemic,D008569: Memory Disorders,D008593: Menopause,D009203: Myocardial Infarction,D010024: Osteoporosis,D011471: Prostatic Neoplasms,D012769: Shock,D013927: Thrombosis,D014424: Turner Syndrome,D015427: Reperfusion Injury,D015663: Osteoporosis, Postmenopausal,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes,D020521: Stroke,D053201: Urinary Bladder, Overactive,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2
Q92731	NA	NA	NA	NA	ESTETROL	Estrogen receptor agonist	AGONIST	2021	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause,D011247: Pregnancy,D011471: Prostatic Neoplasms,D045169: Severe Acute Respiratory Syndrome	ESR2
Q92731	NA	NA	NA	NA	OSPEMIFENE	Estrogen receptor modulator	MODULATOR	2013	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001284: Atrophy,D004414: Dyspareunia,D010145: Paget Disease, Extramammary	ESR2
Q92731	NA	NA	NA	NA	BAZEDOXIFENE ACETATE	Estrogen receptor modulator	MODULATOR	2009	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause,D010024: Osteoporosis,D015663: Osteoporosis, Postmenopausal,D020529: Multiple Sclerosis, Relapsing-Remitting	ESR2
P48443	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D011565: Psoriasis	RXRG
P48443	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRG
P48443	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRG
P48443	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRG
P10828	NA	NA	NA	NA	DEXTROTHYROXINE	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D002318: Cardiovascular Diseases,D004314: Down Syndrome	THRB
P10828	NA	NA	NA	NA	LIOTHYRONINE	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003866: Depressive Disorder,D007037: Hypothyroidism,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	THRB
P10828	NA	NA	NA	NA	LIOTHYRONINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D006258: Head and Neck Neoplasms,D006330: Heart Defects, Congenital,D007037: Hypothyroidism,D009103: Multiple Sclerosis,D013964: Thyroid Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D065630: Hernias, Diaphragmatic, Congenital	THRB
P10828	NA	NA	NA	NA	LEVOTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	2000	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001714: Bipolar Disorder,D003409: Congenital Hypothyroidism,D007037: Hypothyroidism,D010146: Pain,D013964: Thyroid Neoplasms	THRB
P10828	NA	NA	NA	NA	DEXTROTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D009203: Myocardial Infarction,D017202: Myocardial Ischemia	THRB
P50993	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A2
P50993	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2
P50993	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A2
P50993	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2
P19235	NA	NA	NA	NA	EPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	1989	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000740: Anemia,D000751: Anemia, Neonatal,D001237: Asphyxia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D002583: Uterine Cervical Neoplasms,D003327: Coronary Disease,D005221: Fatigue,D005621: Friedreich Ataxia,D006258: Head and Neck Neoplasms,D006323: Heart Arrest,D006526: Hepatitis C,D007676: Kidney Failure, Chronic,D008175: Lung Neoplasms,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D017086: beta-Thalassemia,D019966: Substance-Related Disorders,D020246: Venous Thrombosis,D020521: Stroke,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	EPOR
P19235	NA	NA	NA	NA	DARBEPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	2001	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D004407: Dysgerminoma,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D051436: Renal Insufficiency, Chronic,D055752: Small Cell Lung Carcinoma,D058186: Acute Kidney Injury	EPOR
P19235	NA	NA	NA	NA	PEGINESATIDE ACETATE	Erythropoietin receptor agonist	AGONIST	2012	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia	EPOR
P12259	NA	NA	NA	NA	DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	INHIBITOR	2001	CHEMBL3618	11387	P12259	Coagulation factor V	Homo sapiens	D007022: Hypotension,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013927: Thrombosis,D018805: Sepsis,D020521: Stroke,D051436: Renal Insufficiency, Chronic	F5
P01730	NA	NA	NA	NA	IBALIZUMAB	T-cell surface antigen CD4 inhibitor	INHIBITOR	2018	CHEMBL2754	10476	P01730	T-cell surface glycoprotein CD4	Homo sapiens	D007239: Infections,D014777: Virus Diseases,D015658: HIV Infections	CD4
O95169	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95169	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB8
P30542	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA1
P30542	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA1
P30542	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA1
P30542	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA1
P30542	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA1
P30542	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	NA	ADORA1
P30542	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P30542	Adenosine receptor A1	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA1
O95180	NA	NA	NA	NA	TRIMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1946	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H
O95180	NA	NA	NA	NA	ETHOSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1960	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D003866: Depressive Disorder,D004827: Epilepsy,D004832: Epilepsy, Absence,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome	CACNA1H
O95180	NA	NA	NA	NA	METHSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1957	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H
O95180	NA	NA	NA	NA	PHENSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1982	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H
O95180	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1H
O95180	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1H
O95180	NA	NA	NA	NA	PARAMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1949	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H
O95180	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1H
O95180	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H
O95180	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H
O95180	NA	NA	NA	NA	MIBEFRADIL DIHYDROCHLORIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1997	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H
O95180	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1H
Q13200	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD2
Q13200	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD2
Q13200	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD2
Q9GZV9	NA	NA	NA	NA	BUROSUMAB	Fibroblast growth factor 23 inhibitor	INHIBITOR	2018	CHEMBL3713913	115874	Q9GZV9	Fibroblast growth factor 23	Homo sapiens	D001847: Bone Diseases,D007015: Hypophosphatemia, Familial,D010018: Osteomalacia,D017674: Hypophosphatemia,D053098: Familial Hypophosphatemic Rickets,D063730: Rickets, Hypophosphatemic	FGF23
P54750	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P54750	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE1A
P54750	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P54750	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE1A
P08922	NA	NA	NA	NA	ENTRECTINIB	Proto-oncogene tyrosine-protein kinase ROS inhibitor	INHIBITOR	2019	CHEMBL5568	101019	P08922	Proto-oncogene tyrosine-protein kinase ROS	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	ROS1
Q16718	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q16718	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA5
P31327	NA	NA	NA	NA	CARGLUMIC ACID	Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2010	CHEMBL2362990	105702	P31327	Carbamoyl-phosphate synthase [ammonia], mitochondrial	Homo sapiens	D008661: Metabolism, Inborn Errors,D022124: Hyperammonemia,D056693: Propionic Acidemia	CPS1
Q16739	NA	NA	NA	NA	MIGLUSTAT	Ceramide glucosyltransferase inhibitor	INHIBITOR	2003	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D003550: Cystic Fibrosis,D005776: Gaucher Disease,D006008: Glycogen Storage Disease,D012497: Sandhoff Disease,D015419: Spastic Paraplegia, Hereditary,D015658: HIV Infections,D020143: Gangliosidoses, GM2,D052556: Niemann-Pick Disease, Type C	UGCG
Q16739	NA	NA	NA	NA	ELIGLUSTAT TARTRATE	Ceramide glucosyltransferase inhibitor	INHIBITOR	2014	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D005776: Gaucher Disease	UGCG
P54760	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54760	Ephrin type-B receptor 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB4
P11473	NA	NA	NA	NA	CALCITRIOL	Vitamin D receptor agonist	AGONIST	1978	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D005350: Fibroma,D006973: Hypertension,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007676: Kidney Failure, Chronic,D007713: Klinefelter Syndrome,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009062: Mouth Neoplasms,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D010024: Osteoporosis,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012080: Chronic Kidney Disease-Mineral and Bone Disorder,D015663: Osteoporosis, Postmenopausal,D016543: Central Nervous System Neoplasms,D018281: Cholangiocarcinoma,D018805: Sepsis,D051436: Renal Insufficiency, Chronic,D053098: Familial Hypophosphatemic Rickets,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	VDR
P11473	NA	NA	NA	NA	CHOLECALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000236: Adenoma,D000326: Adrenoleukodystrophy,D000375: Aging,D000740: Anemia,D000755: Anemia, Sickle Cell,D001171: Arthritis, Juvenile,D001249: Asthma,D001321: Autistic Disorder,D001471: Barrett Esophagus,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D001988: Bronchiolitis,D002056: Burns,D002278: Carcinoma in Situ,D002285: Carcinoma, Intraductal, Noninfiltrating,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003139: Common Cold,D003233: Conjunctivitis, Allergic,D003424: Crohn Disease,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D005891: Gingivitis,D005909: Glioblastoma,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006949: Hyperlipidemias,D006967: Hypersensitivity,D007006: Hypogonadism,D007239: Infections,D007248: Infertility, Male,D007251: Influenza, Human,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009103: Multiple Sclerosis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D010212: Papilloma,D010300: Parkinson Disease,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012878: Skin Neoplasms,D013203: Staphylococcal Infections,D013978: Tibial Fractures,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014581: Urticaria,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016481: Helicobacter Infections,D016640: Diabetes, Gestational,D018149: Glucose Intolerance,D018798: Anemia, Iron-Deficiency,D019337: Hematologic Neoplasms,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D055623: Keratosis, Actinic,D055948: Sarcopenia,D060825: Cognitive Dysfunction,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR
P11473	NA	NA	NA	NA	ERGOCALCIFEROL	Vitamin D receptor agonist	AGONIST	1941	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000071698: Latent Autoimmune Diabetes in Adults,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001249: Asthma,D001778: Blood Coagulation Disorders,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D002056: Burns,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004211: Disseminated Intravascular Coagulation,D005265: Femoral Neck Fractures,D005870: Giant Cell Tumors,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006966: Hyperprolactinemia,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007015: Hypophosphatemia, Familial,D007333: Insulin Resistance,D007938: Leukemia,D008175: Lung Neoplasms,D008178: Lupus Erythematosus, Cutaneous,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008593: Menopause,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009369: Neoplasms,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010013: Osteogenesis Imperfecta,D010024: Osteoporosis,D010146: Pain,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012148: Restless Legs Syndrome,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016640: Diabetes, Gestational,D016757: Death, Sudden, Cardiac,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019698: Hepatitis C, Chronic,D019964: Mood Disorders,D020370: Osteoarthritis, Knee,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D049950: Hyperparathyroidism, Primary,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D053098: Familial Hypophosphatemic Rickets,D055948: Sarcopenia,D063730: Rickets, Hypophosphatemic,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR
P11473	NA	NA	NA	NA	PARICALCITOL	Vitamin D receptor agonist	AGONIST	1998	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000419: Albuminuria,D001943: Breast Neoplasms,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D005922: Glomerulonephritis, IGA,D006962: Hyperparathyroidism, Secondary,D006996: Hypocalcemia,D007674: Kidney Diseases,D009101: Multiple Myeloma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010279: Parathyroid Diseases,D011507: Proteinuria,D012004: Rectal Neoplasms,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR
P11473	NA	NA	NA	NA	CALCIPOTRIENE	Vitamin D receptor agonist	AGONIST	1993	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000152: Acne Vulgaris,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D011855: Radiodermatitis,D012594: Scleroderma, Localized,D012871: Skin Diseases,D014820: Vitiligo,D055623: Keratosis, Actinic	VDR
P11473	NA	NA	NA	NA	DOXERCALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D009369: Neoplasms,D010279: Parathyroid Diseases,D011565: Psoriasis,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR
P11473	NA	NA	NA	NA	CALCIFEDIOL	Vitamin D receptor agonist	AGONIST	1980	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D006962: Hyperparathyroidism, Secondary,D009203: Myocardial Infarction,D010279: Parathyroid Diseases,D014808: Vitamin D Deficiency,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D058186: Acute Kidney Injury	VDR
P07949	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2011	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET
P07949	NA	NA	NA	NA	SUNITINIB MALATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2006	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	RET
P07949	NA	NA	NA	NA	SORAFENIB TOSYLATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2005	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET
P07949	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2012	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	RET
P07949	NA	NA	NA	NA	ALECTINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2015	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	RET
P07949	NA	NA	NA	NA	SELPERCATINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms,D018276: Carcinoma, Medullary	RET
P07949	NA	NA	NA	NA	PRALSETINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms	RET
Q9Y375	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9Y375	Complex I intermediate-associated protein 30, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAF1
P05106	NA	NA	NA	NA	EPTIFIBATIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D009203: Myocardial Infarction,D011014: Pneumonia,D012772: Shock, Septic,D013927: Thrombosis,D020520: Brain Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome	ITGB3
P05106	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGB3
P05106	NA	NA	NA	NA	TIROFIBAN HYDROCHLORIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	NA	ITGB3
P18507	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRG2
P18507	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRG2
P18507	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRG2
P18507	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D004827: Epilepsy	GABRG2
P18507	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRG2
P18507	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRG2
P18507	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D008881: Migraine Disorders	GABRG2
P18507	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRG2
P18507	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRG2
P18507	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRG2
P18507	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRG2
P18507	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRG2
P18507	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRG2
P18507	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRG2
P18507	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000647: Amnesia	GABRG2
P18507	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRG2
P18507	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRG2
P18507	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRG2
P18507	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety	GABRG2
P18507	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety	GABRG2
P18507	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety	GABRG2
P18507	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRG2
P18507	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRG2
P18507	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRG2
P18507	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRG2
P18507	NA	NA	NA	NA	ZALEPLON	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1999	CHEMBL2111392	105087	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia	GABRG2
P18507	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRG2
P18507	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRG2
P18507	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRG2
P18507	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRG2
P18507	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D000437: Alcoholism	GABRG2
P18507	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P18507	NA	NA	NA	NA	ZOLPIDEM TARTRATE	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2111392	105087	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity	GABRG2
P18507	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRG2
P18507	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P18507	Gamma-aminobutyric acid receptor subunit gamma-2	Homo sapiens	NA	GABRG2
P47870	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB2
P47870	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB2
P47870	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB2
P47870	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D004827: Epilepsy	GABRB2
P47870	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB2
P47870	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB2
P47870	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D008881: Migraine Disorders	GABRB2
P47870	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB2
P47870	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB2
P47870	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB2
P47870	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB2
P47870	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB2
P47870	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB2
P47870	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB2
P47870	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000647: Amnesia	GABRB2
P47870	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB2
P47870	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB2
P47870	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB2
P47870	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety	GABRB2
P47870	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety	GABRB2
P47870	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety	GABRB2
P47870	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB2
P47870	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB2
P47870	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB2
P47870	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB2
P47870	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB2
P47870	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB2
P47870	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB2
P47870	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB2
P47870	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D000437: Alcoholism	GABRB2
P47870	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P47870	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB2
P47870	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P47870	Gamma-aminobutyric acid receptor subunit beta-2	Homo sapiens	NA	GABRB2
P22459	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA4
P22459	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA4
P22459	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	NA	KCNA4
P22459	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA4
P26358	NA	NA	NA	NA	AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	INHIBITOR	2004	CHEMBL1993	321	P26358	DNA (cytosine-5)-methyltransferase 1	Homo sapiens	D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012516: Osteosarcoma,D013921: Thrombocytopenia,D014376: Tuberculosis,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D017086: beta-Thalassemia,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	DNMT1
P26358	NA	NA	NA	NA	DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	INHIBITOR	2006	CHEMBL1993	321	P26358	DNA (cytosine-5)-methyltransferase 1	Homo sapiens	D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008527: Medulloblastoma,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D013789: Thalassemia,D013921: Thrombocytopenia,D013964: Thyroid Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D016553: Purpura, Thrombocytopenic, Idiopathic,D018263: Adenocarcinoma, Follicular,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045169: Severe Acute Respiratory Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	DNMT1
Q9NQ25	NA	NA	NA	NA	ELOTUZUMAB	SLAM family member 7 inhibitor	INHIBITOR	2015	CHEMBL3559386	109709	Q9NQ25	SLAM family member 7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D007952: Leukemia, Plasma Cell,D009101: Multiple Myeloma,D009369: Neoplasms,D019337: Hematologic Neoplasms,D028226: Amyloidosis, Familial	SLAMF7
P61812	NA	NA	NA	NA	LUSPATERCEPT	Transforming growth factor beta inhibitor	INHIBITOR	2019	CHEMBL3988637	117291	P61812	Transforming growth factor beta-2 proprotein	Homo sapiens	D000740: Anemia,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D011087: Polycythemia Vera,D013789: Thalassemia,D017086: beta-Thalassemia,D055728: Primary Myelofibrosis	TGFB2
P63027	NA	NA	NA	NA	BOTULINUM TOXIN TYPE B	Vesicle-associated membrane protein 2 inhibitor	INHIBITOR	2000	CHEMBL2364160	106139	P63027	Vesicle-associated membrane protein 2	Homo sapiens	D001281: Atrial Fibrillation,D002349: Carpal Tunnel Syndrome,D002547: Cerebral Palsy,D003704: Dementia,D006945: Hyperhidrosis,D012798: Sialorrhea,D012883: Skin Ulcer,D014103: Torticollis	VAMP2
Q14432	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE3A
Q14432	NA	NA	NA	NA	CILOSTAZOL	Phosphodiesterase 3A inhibitor	INHIBITOR	1999	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D002318: Cardiovascular Diseases,D002544: Cerebral Infarction,D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D005234: Fatty Liver,D007383: Intermittent Claudication,D010003: Osteoarthritis,D010146: Pain,D013927: Thrombosis,D016491: Peripheral Vascular Diseases,D020521: Stroke,D046589: CADASIL,D050197: Atherosclerosis,D058729: Peripheral Arterial Disease,D059345: Cerebral Small Vessel Diseases,D060825: Cognitive Dysfunction	PDE3A
Q14432	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE3A
Q14432	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE3A
Q14432	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 3A inhibitor	INHIBITOR	1951	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3A
Q14432	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1981	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3A
Q14432	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 3 inhibitor	INHIBITOR	1982	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A
Q14432	NA	NA	NA	NA	ANAGRELIDE HYDROCHLORIDE	Phosphodiesterase 3 inhibitor	INHIBITOR	1997	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D013920: Thrombocythemia, Essential,D013927: Thrombosis	PDE3A
Q14432	NA	NA	NA	NA	MILRINONE LACTATE	Phosphodiesterase 3A inhibitor	INHIBITOR	1987	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A
Q14432	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE3A
Q14432	NA	NA	NA	NA	INAMRINONE LACTATE	Phosphodiesterase 3A inhibitor	INHIBITOR	1984	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A
Q9H228	NA	NA	NA	NA	FINGOLIMOD HYDROCHLORIDE	Sphingosine 1-phosphate receptor agonist	AGONIST	2010	CHEMBL2363041	105736	Q9H228	Sphingosine 1-phosphate receptor 5	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001943: Breast Neoplasms,D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting	S1PR5
P08172	NA	NA	NA	NA	OXYBUTYNIN CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011471: Prostatic Neoplasms,D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006255: Rhinitis, Allergic, Seasonal,D006945: Hyperhidrosis,D010145: Paget Disease, Extramammary,D011115: Polyneuropathies,D011141: Polyuria,D012891: Sleep Apnea Syndromes,D014549: Urinary Incontinence,D020181: Sleep Apnea, Obstructive,D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1953	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM2
P08172	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2
P08172	NA	NA	NA	NA	BETHANECHOL CHLORIDE	Muscarinic acetylcholine receptor M2 agonist	AGONIST	1948	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2
P08172	NA	NA	NA	NA	SOLIFENACIN SUCCINATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011470: Prostatic Hyperplasia,D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	DARIFENACIN HYDROBROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2
P08172	NA	NA	NA	NA	FESOTERODINE FUMARATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2008	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	TOLTERODINE TARTRATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1998	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2
P08172	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM2
P08172	NA	NA	NA	NA	TROSPIUM CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D053201: Urinary Bladder, Overactive	CHRM2
P49840	NA	NA	NA	NA	LITHIUM CARBONATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1970	CHEMBL2095188	104772	P49840	Glycogen synthase kinase-3 alpha	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001714: Bipolar Disorder,D001924: Brain Concussion,D001932: Brain Neoplasms,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D013494: Supranuclear Palsy, Progressive,D016543: Central Nervous System Neoplasms,D017827: Machado-Joseph Disease,D018276: Carcinoma, Medullary,D018358: Neuroendocrine Tumors,D019578: Multiple System Atrophy,D019955: Conduct Disorder,D020521: Stroke,D020754: Spinocerebellar Ataxias,D050723: Fractures, Bone,D052556: Niemann-Pick Disease, Type C,D055752: Small Cell Lung Carcinoma,D057180: Frontotemporal Dementia,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	GSK3A
P49840	NA	NA	NA	NA	LITHIUM CITRATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1980	CHEMBL2095188	104772	P49840	Glycogen synthase kinase-3 alpha	Homo sapiens	D011618: Psychotic Disorders	GSK3A
P49005	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2
P49005	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD2
P49005	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD2
P49005	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2
Q9BQ31	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNS3
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNS3
Q9BQ31	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	NA	KCNS3
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNS3
Q12879	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2A
Q12879	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2A
Q12879	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2A
Q12879	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2A
Q12879	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2A
Q12879	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010146: Pain	GRIN2A
Q12879	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010300: Parkinson Disease	GRIN2A
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1982	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D002659: Child Development Disorders, Pervasive	GRIN2A
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1984	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	GRIN2A
Q12879	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000437: Alcoholism	GRIN2A
Q12879	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2A
P37088	NA	NA	NA	NA	TRIAMTERENE	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	1964	CHEMBL2107836	104888	P37088	Amiloride-sensitive sodium channel subunit alpha	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004487: Edema,D006333: Heart Failure,D006929: Hyperaldosteronism,D006937: Hypercholesterolemia,D006973: Hypertension,D008103: Liver Cirrhosis,D009404: Nephrotic Syndrome,D016757: Death, Sudden, Cardiac,D050197: Atherosclerosis	SCNN1A
P37088	NA	NA	NA	NA	AMILORIDE HYDROCHLORIDE	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	1981	CHEMBL2107836	104888	P37088	Amiloride-sensitive sodium channel subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac,D003550: Cystic Fibrosis,D006333: Heart Failure,D006973: Hypertension	SCNN1A
P11836	NA	NA	NA	NA	IBRITUMOMAB TIUXETAN	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2002	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D002051: Burkitt Lymphoma,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	MS4A1
P11836	NA	NA	NA	NA	TOSITUMOMAB	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2003	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D020522: Lymphoma, Mantle-Cell	MS4A1
P11836	NA	NA	NA	NA	RITUXIMAB	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	1997	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000741: Anemia, Aplastic,D000744: Anemia, Hemolytic, Autoimmune,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D001528: Behcet Syndrome,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002178: Candidiasis, Chronic Mucocutaneous,D002294: Carcinoma, Squamous Cell,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003424: Crohn Disease,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D003929: Diabetic Neuropathies,D004672: Encephalitis, Japanese,D004679: Encephalomyelitis,D005199: Fanconi Anemia,D005733: Gangliosidoses,D005871: Castleman Disease,D005921: Glomerulonephritis,D005923: Glomerulosclerosis, Focal Segmental,D006009: Glycogen Storage Disease Type II,D006086: Graft vs Host Disease,D006333: Heart Failure,D006402: Hematologic Diseases,D006463: Hemolytic-Uremic Syndrome,D006467: Hemophilia A,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007946: Leukemia, Mast-Cell,D008105: Liver Cirrhosis, Biliary,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D010523: Peripheral Nervous System Diseases,D011008: Pneumococcal Infections,D011115: Polyneuropathies,D011507: Proteinuria,D011649: Pulmonary Alveolar Proteinosis,D011697: Purpura, Thrombotic Thrombocytopenic,D012507: Sarcoidosis,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012859: Sjogren's Syndrome,D013167: Spondylitis, Ankylosing,D013274: Stomach Neoplasms,D014581: Urticaria,D014890: Granulomatosis with Polyangiitis,D015267: Churg-Strauss Syndrome,D015423: Scleritis,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015535: Arthritis, Psoriatic,D015673: Fatigue Syndrome, Chronic,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016553: Purpura, Thrombocytopenic, Idiopathic,D016736: Antiphospholipid Syndrome,D016750: Stiff-Person Syndrome,D017563: Lung Diseases, Interstitial,D017728: Lymphoma, Large-Cell, Anaplastic,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D019578: Multiple System Atrophy,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D049970: Graves Ophthalmopathy,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055953: Microscopic Polyangiitis,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,D064129: Prostatic Neoplasms, Castration-Resistant	MS4A1
P11836	NA	NA	NA	NA	OFATUMUMAB	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2009	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001172: Arthritis, Rheumatoid,D002051: Burkitt Lymphoma,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D009103: Multiple Sclerosis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010392: Pemphigus,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	MS4A1
P11836	NA	NA	NA	NA	OBINUTUZUMAB	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2013	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D002051: Burkitt Lymphoma,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007674: Kidney Diseases,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009182: Mycosis Fungoides,D009369: Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D020522: Lymphoma, Mantle-Cell,D051436: Renal Insufficiency, Chronic	MS4A1
P11836	NA	NA	NA	NA	OCRELIZUMAB	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2017	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D001172: Arthritis, Rheumatoid,D004672: Encephalitis, Japanese,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D009103: Multiple Sclerosis,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	MS4A1
P11836	NA	NA	NA	NA	YTTRIUM Y 90 IBRITUMOMAB TIUXETAN	B-lymphocyte antigen CD20 binding agent	BINDING AGENT	2002	CHEMBL2058	181	P11836	B-lymphocyte antigen CD20	Homo sapiens	D002051: Burkitt Lymphoma,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D017728: Lymphoma, Large-Cell, Anaplastic,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	MS4A1
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2
P49286	NA	NA	NA	NA	RAMELTEON	Melatonin receptor agonist	AGONIST	2005	CHEMBL2094268	104733	P49286	Melatonin receptor type 1B	Homo sapiens	D001714: Bipolar Disorder,D002056: Burns,D002189: Marijuana Abuse,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019966: Substance-Related Disorders,D020181: Sleep Apnea, Obstructive,D020325: Migraine with Aura,D020326: Migraine without Aura,D029424: Pulmonary Disease, Chronic Obstructive	MTNR1B
P49286	NA	NA	NA	NA	TASIMELTEON	Melatonin receptor agonist	AGONIST	2014	CHEMBL2094268	104733	P49286	Melatonin receptor type 1B	Homo sapiens	D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D012893: Sleep Wake Disorders,D020178: Sleep Disorders, Circadian Rhythm,D058496: Smith-Magenis Syndrome	MTNR1B
P03956	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1967	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP1
P03956	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1974	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D010019: Osteomyelitis	MMP1
P03956	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1967	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP1
P54756	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54756	Ephrin type-A receptor 5	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA5
P18545	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6G
P18545	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6G
Q15878	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1E
Q15878	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1E
Q15878	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1E
Q15878	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	NA	CACNA1E
Q15878	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	NA	CACNA1E
Q15878	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1E
P12268	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH2
P12268	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH2
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH2
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	NA	IMPDH2
O60359	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG3
O60359	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG3
O60359	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG3
O60359	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3
O60359	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3
O60359	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG3
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR
P49841	NA	NA	NA	NA	LITHIUM CARBONATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1970	CHEMBL2095188	104772	P49841	Glycogen synthase kinase-3 beta	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001714: Bipolar Disorder,D001924: Brain Concussion,D001932: Brain Neoplasms,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D013494: Supranuclear Palsy, Progressive,D016543: Central Nervous System Neoplasms,D017827: Machado-Joseph Disease,D018276: Carcinoma, Medullary,D018358: Neuroendocrine Tumors,D019578: Multiple System Atrophy,D019955: Conduct Disorder,D020521: Stroke,D020754: Spinocerebellar Ataxias,D050723: Fractures, Bone,D052556: Niemann-Pick Disease, Type C,D055752: Small Cell Lung Carcinoma,D057180: Frontotemporal Dementia,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	GSK3B
P49841	NA	NA	NA	NA	LITHIUM CITRATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1980	CHEMBL2095188	104772	P49841	Glycogen synthase kinase-3 beta	Homo sapiens	D011618: Psychotic Disorders	GSK3B
O94806	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	O94806	Serine/threonine-protein kinase D3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD3
P35367	NA	NA	NA	NA	TERFENADINE	Histamine H1 receptor antagonist	ANTAGONIST	1985	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D001249: Asthma,D003699: Hepatitis D,D006967: Hypersensitivity,D009103: Multiple Sclerosis,D016403: Lymphoma, Large B-Cell, Diffuse,D019694: Hepatitis B, Chronic	HRH1
P35367	NA	NA	NA	NA	ASTEMIZOLE	Histamine H1 receptor antagonist	ANTAGONIST	1988	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006967: Hypersensitivity	HRH1
P35367	NA	NA	NA	NA	LORATADINE	Histamine H1 receptor antagonist	ANTAGONIST	1993	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001416: Back Pain,D001943: Breast Neoplasms,D003876: Dermatitis, Atopic,D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D008223: Lymphoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D012221: Rhinitis, Allergic, Perennial,D014581: Urticaria,D057765: Eosinophilic Esophagitis	HRH1
P35367	NA	NA	NA	NA	DESLORATADINE	Histamine H1 receptor antagonist	ANTAGONIST	2001	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D003139: Common Cold,D003233: Conjunctivitis, Allergic,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D011537: Pruritus,D012221: Rhinitis, Allergic, Perennial,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	ACRIVASTINE	Histamine H1 receptor antagonist	ANTAGONIST	1994	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006967: Hypersensitivity	HRH1
P35367	NA	NA	NA	NA	DIPHENYLPYRALINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	DIPHENHYDRAMINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1946	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D001943: Breast Neoplasms,D003929: Diabetic Neuropathies,D006255: Rhinitis, Allergic, Seasonal,D006261: Headache,D006967: Hypersensitivity,D007024: Hypotension, Orthostatic,D007680: Kidney Neoplasms,D010146: Pain,D012004: Rectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	HRH1
P35367	NA	NA	NA	NA	KETOTIFEN FUMARATE	Histamine H1 receptor antagonist	ANTAGONIST	1999	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D003872: Dermatitis,D003876: Dermatitis, Atopic,D012221: Rhinitis, Allergic, Perennial,D050723: Fractures, Bone,D059350: Chronic Pain	HRH1
P35367	NA	NA	NA	NA	PHENIRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1994	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003139: Common Cold,D007251: Influenza, Human,D012141: Respiratory Tract Infections	HRH1
P35367	NA	NA	NA	NA	CHLORPHENIRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1950	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003371: Cough,D006255: Rhinitis, Allergic, Seasonal,D012852: Sinusitis,D013471: Sunburn	HRH1
P35367	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Histamine H1 receptor agonist	AGONIST	1985	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	CYPROHEPTADINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1961	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D009369: Neoplasms	HRH1
P35367	NA	NA	NA	NA	OLOPATADINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1996	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D006255: Rhinitis, Allergic, Seasonal,D011537: Pruritus	HRH1
P35367	NA	NA	NA	NA	DOXYLAMINE SUCCINATE	Histamine H1 receptor antagonist	ANTAGONIST	1948	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D007239: Infections,D020250: Postoperative Nausea and Vomiting	HRH1
P35367	NA	NA	NA	NA	ORPHENADRINE CITRATE	Histamine H1 receptor antagonist	ANTAGONIST	1959	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D010146: Pain	HRH1
P35367	NA	NA	NA	NA	DIMENHYDRINATE	Histamine H1 receptor antagonist	ANTAGONIST	1972	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D014717: Vertigo,D014839: Vomiting,D020250: Postoperative Nausea and Vomiting	HRH1
P35367	NA	NA	NA	NA	TRIPELENNAMINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1948	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	HYDROXYZINE PAMOATE	Histamine H1 receptor antagonist	ANTAGONIST	1959	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D009497: Neurotic Disorders,D011537: Pruritus,D012871: Skin Diseases,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	EPINASTINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	2003	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic	HRH1
P35367	NA	NA	NA	NA	CYCLIZINE LACTATE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	METHDILAZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	ANTAZOLINE PHOSPHATE	Histamine H1 receptor antagonist	ANTAGONIST	1994	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	FEXOFENADINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1996	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D007669: Kidney Calculi,D012221: Rhinitis, Allergic, Perennial	HRH1
P35367	NA	NA	NA	NA	DEXBROMPHENIRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1963	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	PROMETHAZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1951	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006939: Hyperemesis Gravidarum,D006967: Hypersensitivity,D007319: Sleep Initiation and Maintenance Disorders,D010146: Pain,D020325: Migraine with Aura,D020326: Migraine without Aura	HRH1
P35367	NA	NA	NA	NA	TRIPELENNAMINE CITRATE	Histamine H1 receptor antagonist	ANTAGONIST	1948	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	CLEMASTINE FUMARATE	Histamine H1 receptor antagonist	ANTAGONIST	1977	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006967: Hypersensitivity,D009103: Multiple Sclerosis	HRH1
P35367	NA	NA	NA	NA	AZELASTINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1996	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D006255: Rhinitis, Allergic, Seasonal,D012221: Rhinitis, Allergic, Perennial,D012223: Rhinitis, Vasomotor	HRH1
P35367	NA	NA	NA	NA	DEXCHLORPHENIRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1981	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D000799: Angioedema,D003233: Conjunctivitis, Allergic,D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D009103: Multiple Sclerosis,D012221: Rhinitis, Allergic, Perennial,D012223: Rhinitis, Vasomotor,D013471: Sunburn,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1979	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	METHDILAZINE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006967: Hypersensitivity	HRH1
P35367	NA	NA	NA	NA	BROMPHENIRAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1957	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003139: Common Cold,D003371: Cough,D006967: Hypersensitivity	HRH1
P35367	NA	NA	NA	NA	BROMODIPHENHYDRAMINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1954	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	CARBINOXAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	2003	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D000799: Angioedema,D003233: Conjunctivitis, Allergic,D006255: Rhinitis, Allergic, Seasonal,D012221: Rhinitis, Allergic, Perennial,D012223: Rhinitis, Vasomotor,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	PYRILAMINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1973	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1957	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D010300: Parkinson Disease	HRH1
P35367	NA	NA	NA	NA	PROPIOMAZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1960	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	DIPHENHYDRAMINE CITRATE	Histamine H1 receptor antagonist	ANTAGONIST	2005	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D008881: Migraine Disorders,D013281: Stomatitis, Aphthous	HRH1
P35367	NA	NA	NA	NA	LEVOCETIRIZINE DIHYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	2007	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003371: Cough,D006255: Rhinitis, Allergic, Seasonal,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D012220: Rhinitis,D012877: Skin Manifestations,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	CHLORPHENIRAMINE POLISTIREX	Histamine H1 receptor antagonist	ANTAGONIST	1984	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	ALCAFTADINE	Histamine H1 receptor antagonist	ANTAGONIST	2010	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D005132: Eye Manifestations	HRH1
P35367	NA	NA	NA	NA	BEPOTASTINE BESYLATE	Histamine H1 receptor antagonist	ANTAGONIST	2009	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D011537: Pruritus,D012221: Rhinitis, Allergic, Perennial	HRH1
P35367	NA	NA	NA	NA	LEVOCABASTINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1993	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D012221: Rhinitis, Allergic, Perennial	HRH1
P35367	NA	NA	NA	NA	CETIRIZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1995	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D011472: Prostatitis,D014581: Urticaria	HRH1
P35367	NA	NA	NA	NA	EMEDASTINE DIFUMARATE	Histamine H1 receptor antagonist	ANTAGONIST	1997	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	BUCLIZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	HYDROXYZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1956	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	TRIPROLIDINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1983	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	AZATADINE MALEATE	Histamine H1 receptor antagonist	ANTAGONIST	1977	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	HISTAMINE PHOSPHATE	Histamine H1 receptor agonist	AGONIST	1939	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
P35367	NA	NA	NA	NA	MECLIZINE HYDROCHLORIDE	Histamine H1 receptor antagonist	ANTAGONIST	1957	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	D009041: Motion Sickness,D014717: Vertigo,D014839: Vomiting	HRH1
P35367	NA	NA	NA	NA	TRIMEPRAZINE TARTRATE	Histamine H1 receptor antagonist	ANTAGONIST	1982	CHEMBL231	127	P35367	Histamine H1 receptor	Homo sapiens	NA	HRH1
O15399	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2D
O15399	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2D
O15399	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2D
O15399	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2D
O15399	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2D
O15399	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010146: Pain	GRIN2D
O15399	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010300: Parkinson Disease	GRIN2D
O15399	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000437: Alcoholism	GRIN2D
O15399	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2D
Q15375	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	Q15375	Ephrin type-A receptor 7	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA7
Q8TDN1	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG4
Q8TDN1	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG4
Q8TDN1	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	NA	KCNG4
Q8TDN1	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG4
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D
P05023	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A1
P05023	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A1
P05023	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A1
P05023	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A1
P05129	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	P05129	Protein kinase C gamma type	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKCG
Q07864	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q07864	DNA polymerase epsilon catalytic subunit A	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE
Q07864	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q07864	DNA polymerase epsilon catalytic subunit A	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLE
Q07864	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q07864	DNA polymerase epsilon catalytic subunit A	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLE
Q07864	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q07864	DNA polymerase epsilon catalytic subunit A	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE
Q01344	NA	NA	NA	NA	BENRALIZUMAB	Interleukin-5 receptor subunit alpha inhibitor	INHIBITOR	2017	CHEMBL3580483	109779	Q01344	Interleukin-5 receptor subunit alpha	Homo sapiens	D001249: Asthma,D003876: Dermatitis, Atopic,D006402: Hematologic Diseases,D008173: Lung Diseases, Obstructive,D009298: Nasal Polyps,D010391: Pemphigoid, Bullous,D012852: Sinusitis,D014581: Urticaria,D017681: Hypereosinophilic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D057765: Eosinophilic Esophagitis	IL5RA
Q15842	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 8 opener	OPENER	1973	CHEMBL4770	10891	Q15842	ATP-sensitive inward rectifier potassium channel 8	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ8
P17980	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC3
P17980	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC3
P17980	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC3
Q04844	NA	NA	NA	NA	SUCCINYLCHOLINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor agonist	AGONIST	1952	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	MIVACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1992	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	D008107: Liver Diseases	CHRNE
Q04844	NA	NA	NA	NA	DECAMETHONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	METOCURINE IODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	ATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1983	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	D009126: Muscle Relaxation	CHRNE
Q04844	NA	NA	NA	NA	RAPACURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1999	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	VECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1984	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	CISATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1995	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	D012128: Respiratory Distress Syndrome	CHRNE
Q04844	NA	NA	NA	NA	ROCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1994	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	D001416: Back Pain,D006323: Heart Arrest	CHRNE
Q04844	NA	NA	NA	NA	PIPECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1990	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	PANCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1972	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	GALLAMINE TRIETHIODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	DOXACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1991	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q04844	NA	NA	NA	NA	TUBOCURARINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1945	CHEMBL2362997	105709	Q04844	Acetylcholine receptor subunit epsilon	Homo sapiens	NA	CHRNE
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3
Q71U36	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1A
Q71U36	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1A
Q71U36	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1A
Q71U36	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1A
Q71U36	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1A
Q71U36	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1A
Q71U36	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1A
Q71U36	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1A
Q71U36	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q71U36	Tubulin alpha-1A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1A
P55036	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4
P55036	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4
P55036	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD4
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C
P35498	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN1A
P35498	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN1A
P35498	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN1A
P35498	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A
P35498	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN1A
P35498	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN1A
P35498	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN1A
P35498	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN1A
P35498	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN1A
P35498	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A
P35498	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A
P35498	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN1A
P35498	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN1A
P35498	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN1A
P35498	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN1A
P35498	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A
P35498	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN1A
P35498	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN1A
P35498	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010146: Pain	SCN1A
P35498	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN1A
P35498	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN1A
P35498	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN1A
P35498	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A
P35498	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN1A
P35498	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN1A
P35498	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A
P35498	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN1A
P35498	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN1A
P35498	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN1A
P35498	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN1A
P35498	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN1A
P35498	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A
P35498	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN1A
P35498	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN1A
P49821	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	P49821	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFV1
Q4U2R8	NA	NA	NA	NA	PROBENECID	Solute carrier family 22 member 6 inhibitor	INHIBITOR	1951	CHEMBL1641347	103829	Q4U2R8	Solute carrier family 22 member 6	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D002481: Cellulitis,D002805: Chondrocalcinosis,D003924: Diabetes Mellitus, Type 2,D005585: Influenza in Birds,D006073: Gout,D006333: Heart Failure,D007239: Infections,D009369: Neoplasms,D009765: Obesity,D014552: Urinary Tract Infections,D054143: Heart Failure, Systolic	SLC22A6
P04626	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2
P04626	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB2
P04626	NA	NA	NA	NA	LAPATINIB DITOSYLATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2007	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2
P04626	NA	NA	NA	NA	TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	1998	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004806: Ependymoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D007340: Insulinoma,D007938: Leukemia,D008175: Lung Neoplasms,D008228: Lymphoma, Non-Hodgkin,D009182: Mycosis Fungoides,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010282: Parathyroid Neoplasms,D010490: Pericardial Effusion,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018567: Breast Neoplasms, Male,D044584: Carcinoma, Ductal,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2
P04626	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	ERBB2
P04626	NA	NA	NA	NA	PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2012	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D018278: Carcinoma, Neuroendocrine,D018567: Breast Neoplasms, Male,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2
P04626	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB2
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB2
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB2
P04626	NA	NA	NA	NA	MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2
P04626	NA	NA	NA	NA	TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D008107: Liver Diseases,D009369: Neoplasms	ERBB2
P04626	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2
P04626	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	Receptor protein-tyrosine kinase erbB-2 binding agent	BINDING AGENT	2019	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	ERBB2
P54284	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB3
P54284	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB3
P54284	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNB3
P54284	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3
P54284	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3
P54284	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB3
Q13224	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2B
Q13224	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2B
Q13224	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2B
Q13224	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2B
Q13224	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2B
Q13224	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D010146: Pain	GRIN2B
Q13224	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D010300: Parkinson Disease	GRIN2B
Q13224	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D000437: Alcoholism	GRIN2B
Q13224	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q13224	Glutamate receptor ionotropic, NMDA 2B	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2B
P40259	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	B-cell antigen receptor complex-associated protein beta chain binding agent	BINDING AGENT	2019	CHEMBL3712852	114813	P40259	B-cell antigen receptor complex-associated protein beta chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	CD79B
P56524	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC4
P56524	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC4
P56524	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D009101: Multiple Myeloma	HDAC4
Q14654	NA	NA	NA	NA	GLYBURIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000083242: Ischemic Stroke,D001930: Brain Injuries,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D013119: Spinal Cord Injuries,D016640: Diabetes, Gestational,D020521: Stroke,D060050: Angina, Stable	KCNJ11
Q14654	NA	NA	NA	NA	CHLORPROPAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1958	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11
Q14654	NA	NA	NA	NA	TOLBUTAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D008223: Lymphoma,D009369: Neoplasms,D019698: Hepatitis C, Chronic,D059350: Chronic Pain	KCNJ11
Q14654	NA	NA	NA	NA	NATEGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	2000	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11
Q14654	NA	NA	NA	NA	MINOXIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1979	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000505: Alopecia,D006973: Hypertension	KCNJ11
Q14654	NA	NA	NA	NA	TOLAZAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1966	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11
Q14654	NA	NA	NA	NA	GLIPIZIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	KCNJ11
Q14654	NA	NA	NA	NA	REPAGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1997	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D010300: Parkinson Disease,D028361: Mitochondrial Diseases,D046152: Gastrointestinal Stromal Tumors,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	KCNJ11
Q14654	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	OPENER	1973	CHEMBL1886	285	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ11
Q14654	NA	NA	NA	NA	GLIMEPIRIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1995	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	KCNJ11
Q14654	NA	NA	NA	NA	ACETOHEXAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1964	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D002386: Cataract,D003920: Diabetes Mellitus	KCNJ11
Q14654	NA	NA	NA	NA	PINACIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1989	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D006973: Hypertension	KCNJ11
Q14654	NA	NA	NA	NA	TOLBUTAMIDE SODIUM, STERILE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	NA	KCNJ11
Q09428	NA	NA	NA	NA	GLYBURIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D000083242: Ischemic Stroke,D001930: Brain Injuries,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D013119: Spinal Cord Injuries,D016640: Diabetes, Gestational,D020521: Stroke,D060050: Angina, Stable	ABCC8
Q09428	NA	NA	NA	NA	CHLORPROPAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1958	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8
Q09428	NA	NA	NA	NA	TOLBUTAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D008223: Lymphoma,D009369: Neoplasms,D019698: Hepatitis C, Chronic,D059350: Chronic Pain	ABCC8
Q09428	NA	NA	NA	NA	NATEGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	2000	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8
Q09428	NA	NA	NA	NA	TOLAZAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1966	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8
Q09428	NA	NA	NA	NA	GLIPIZIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	ABCC8
Q09428	NA	NA	NA	NA	REPAGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1997	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D010300: Parkinson Disease,D028361: Mitochondrial Diseases,D046152: Gastrointestinal Stromal Tumors,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ABCC8
Q09428	NA	NA	NA	NA	GLIMEPIRIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1995	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	ABCC8
Q09428	NA	NA	NA	NA	ACETOHEXAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1964	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D002386: Cataract,D003920: Diabetes Mellitus	ABCC8
Q09428	NA	NA	NA	NA	TOLBUTAMIDE SODIUM, STERILE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	NA	ABCC8
P29322	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29322	Ephrin type-A receptor 8	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA8
P21860	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P21860	Receptor tyrosine-protein kinase erbB-3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB3
P22001	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA3
P22001	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA3
P22001	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	NA	KCNA3
P22001	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA3
P27487	NA	NA	NA	NA	ALOGLIPTIN BENZOATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2013	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4
P27487	NA	NA	NA	NA	LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2011	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004938: Esophageal Neoplasms,D006973: Hypertension,D012140: Respiratory Tract Diseases,D012559: Schizophrenia,D013274: Stomach Neoplasms,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency	DPP4
P27487	NA	NA	NA	NA	SITAGLIPTIN PHOSPHATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2006	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006949: Hyperlipidemias,D009203: Myocardial Infarction,D020521: Stroke,D051437: Renal Insufficiency	DPP4
P27487	NA	NA	NA	NA	SAXAGLIPTIN HYDROCHLORIDE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2009	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4
P54762	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54762	Ephrin type-B receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB1
Q99460	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1
Q99460	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1
Q99460	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD1
P31350	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2
P31350	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2
P31350	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2
P31350	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2
P31350	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2
P11926	NA	NA	NA	NA	EFLORNITHINE HYDROCHLORIDE	Ornithine decarboxylase inhibitor	INHIBITOR	1990	CHEMBL1869	272	P11926	Ornithine decarboxylase	Homo sapiens	D009447: Neuroblastoma,D011125: Adenomatous Polyposis Coli,D018305: Ganglioneuroblastoma	ODC1
Q02880	NA	NA	NA	NA	ETOPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1983	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000163: Acquired Immunodeficiency Syndrome,D000306: Adrenal Cortex Neoplasms,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002822: Choriocarcinoma,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005910: Glioma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008479: Mediastinal Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009396: Wilms Tumor,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018236: Carcinoma, Embryonal,D018239: Seminoma,D018240: Endodermal Sinus Tumor,D018242: Neuroectodermal Tumors, Primitive,D018273: Carcinoma, Islet Cell,D018278: Carcinoma, Neuroendocrine,D018302: Neoplasms, Neuroepithelial,D018305: Ganglioneuroblastoma,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020339: Optic Nerve Glioma,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP2B
Q02880	NA	NA	NA	NA	TENIPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1992	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D009369: Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	TOP2B
P17752	NA	NA	NA	NA	TELOTRISTAT ETHYL	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	2017	CHEMBL3831287	116867	P17752	Tryptophan 5-hydroxylase 1	Homo sapiens	D001661: Biliary Tract Neoplasms,D002275: Carcinoid Heart Disease,D008107: Liver Diseases,D008303: Malignant Carcinoid Syndrome,D018358: Neuroendocrine Tumors	TPH1
P17752	NA	NA	NA	NA	TELOTRISTAT ETIPRATE	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	2017	CHEMBL3831287	116867	P17752	Tryptophan 5-hydroxylase 1	Homo sapiens	D003967: Diarrhea	TPH1
P02708	NA	NA	NA	NA	SUCCINYLCHOLINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor agonist	AGONIST	1952	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	MIVACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1992	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D008107: Liver Diseases	CHRNA1
P02708	NA	NA	NA	NA	DECAMETHONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	METOCURINE IODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	ATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1983	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D009126: Muscle Relaxation	CHRNA1
P02708	NA	NA	NA	NA	RAPACURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1999	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	VECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1984	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	CISATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1995	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D012128: Respiratory Distress Syndrome	CHRNA1
P02708	NA	NA	NA	NA	ROCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1994	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D001416: Back Pain,D006323: Heart Arrest	CHRNA1
P02708	NA	NA	NA	NA	PIPECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1990	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	PANCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1972	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	GALLAMINE TRIETHIODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	DOXACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1991	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
P02708	NA	NA	NA	NA	TUBOCURARINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1945	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1
O00305	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB4
O00305	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB4
O00305	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	D002318: Cardiovascular Diseases	CACNB4
O00305	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	NA	CACNB4
O00305	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	NA	CACNB4
O00305	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O00305	Voltage-dependent L-type calcium channel subunit beta-4	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB4
P18054	NA	NA	NA	NA	BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	1982	CHEMBL3687	11134	P18054	Polyunsaturated fatty acid lipoxygenase ALOX12	Homo sapiens	D012216: Rheumatic Diseases	ALOX12
O43920	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O43920	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS5
P08887	NA	NA	NA	NA	TOCILIZUMAB	Interleukin-6 receptor alpha subunit inhibitor	INHIBITOR	2005	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D005334: Fever,D005357: Fibrous Dysplasia of Bone,D005871: Castleman Disease,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006528: Carcinoma, Hepatocellular,D006976: Hypertension, Pulmonary,D007154: Immune System Diseases,D007938: Leukemia,D008113: Liver Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009471: Neuromyelitis Optica,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010505: Familial Mediterranean Fever,D011014: Pneumonia,D011024: Pneumonia, Viral,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D013625: Takayasu Arteritis,D013700: Giant Cell Arteritis,D014605: Uveitis,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015866: Uveitis, Posterior,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016706: Still's Disease, Adult-Onset,D019337: Hematologic Neoplasms,D031249: Erdheim-Chester Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome	IL6R
P08887	NA	NA	NA	NA	SARILUMAB	Interleukin-6 receptor alpha subunit antagonist	ANTAGONIST	2017	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D007154: Immune System Diseases,D011111: Polymyalgia Rheumatica,D012594: Scleroderma, Localized,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D034721: Mastocytosis, Systemic,D045169: Severe Acute Respiratory Syndrome	IL6R
P08887	NA	NA	NA	NA	SATRALIZUMAB	IL6Ralpha/GP130 antagonist	ANTAGONIST	2020	CHEMBL3137266	108122	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D007154: Immune System Diseases,D009471: Neuromyelitis Optica	IL6R
O75306	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O75306	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS2
Q9UQL6	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC5
Q9UQL6	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC5
Q9UQL6	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D009101: Multiple Myeloma	HDAC5
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1
O14980	NA	NA	NA	NA	SELINEXOR	Exportin-1 inhibitor	INHIBITOR	2019	CHEMBL5661	101280	O14980	Exportin-1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D008080: Liposarcoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	XPO1
P09769	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P09769	Tyrosine-protein kinase Fgr	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FGR
P35354	NA	NA	NA	NA	INDOMETHACIN	Cyclooxygenase inhibitor	INHIBITOR	1965	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000081483: Squamous Intraepithelial Lesions,D000544: Alzheimer Disease,D001249: Asthma,D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D004374: Ductus Arteriosus, Patent,D005128: Eye Diseases,D006073: Gout,D006470: Hemorrhage,D006646: Histiocytosis, Langerhans-Cell,D007024: Hypotension, Orthostatic,D007249: Inflammation,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008545: Melanoma,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D014098: Toothache,D015210: Arthritis, Gouty,D018771: Arthralgia,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D050500: Pancreatitis, Chronic,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2
P35354	NA	NA	NA	NA	SULFASALAZINE	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D005909: Glioblastoma,D006976: Hypertension, Pulmonary,D007415: Intestinal Obstruction,D009325: Nausea,D010019: Osteomyelitis,D010523: Peripheral Nervous System Diseases,D013167: Spondylitis, Ankylosing,D015209: Cholangitis, Sclerosing,D015535: Arthritis, Psoriatic	PTGS2
P35354	CHEMBL25	1280	2244	DB00945	ASPIRIN	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000026: Abortion, Habitual,D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000077192: Adenocarcinoma of Lung,D000083242: Ischemic Stroke,D000236: Adenoma,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001249: Asthma,D001281: Atrial Fibrillation,D001471: Barrett Esophagus,D001714: Bipolar Disorder,D001766: Blindness,D001778: Blood Coagulation Disorders,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002386: Cataract,D002532: Intracranial Aneurysm,D002537: Intracranial Arteriosclerosis,D002544: Cerebral Infarction,D002546: Ischemic Attack, Transient,D002561: Cerebrovascular Disorders,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003139: Common Cold,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D004066: Digestive System Diseases,D004211: Disseminated Intravascular Coagulation,D004381: Duodenal Ulcer,D004938: Esophageal Neoplasms,D005221: Fatigue,D005317: Fetal Growth Retardation,D005334: Fever,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006261: Headache,D006331: Heart Diseases,D006333: Heart Failure,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006528: Carcinoma, Hepatocellular,D006561: Herpes Simplex,D006562: Herpes Zoster,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007511: Ischemia,D007972: Leukoplakia, Oral,D008180: Lupus Erythematosus, Systemic,D008268: Macular Degeneration,D008545: Melanoma,D008581: Meningitis,D008881: Migraine Disorders,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010003: Osteoarthritis,D010020: Osteonecrosis,D010051: Ovarian Neoplasms,D010146: Pain,D010437: Peptic Ulcer,D010518: Periodontitis,D010612: Pharyngitis,D010927: Placental Insufficiency,D011014: Pneumonia,D011024: Pneumonia, Viral,D011087: Polycythemia Vera,D011125: Adenomatous Polyposis Coli,D011225: Pre-Eclampsia,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012170: Retinal Vein Occlusion,D012214: Rheumatic Heart Disease,D012559: Schizophrenia,D013035: Spasm,D013274: Stomach Neoplasms,D013276: Stomach Ulcer,D013920: Thrombocythemia, Essential,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014376: Tuberculosis,D014456: Ulcer,D014647: Varicose Ulcer,D014652: Vascular Diseases,D014808: Vitamin D Deficiency,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015356: Retinal Artery Occlusion,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016889: Endometrial Neoplasms,D016893: Carotid Stenosis,D017116: Low Back Pain,D017202: Myocardial Ischemia,D018781: Tension-Type Headache,D018805: Sepsis,D019851: Thrombophilia,D020246: Venous Thrombosis,D020520: Brain Infarction,D020521: Stroke,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D050197: Atherosclerosis,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D055371: Acute Lung Injury,D056586: Acute Chest Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable,D061218: Depressive Disorder, Treatment-Resistant,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2
P35354	CHEMBL521	11674	3672	DB01050	IBUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1974	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000532: Altitude Sickness,D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D001997: Bronchopulmonary Dysplasia,D002056: Burns,D002318: Cardiovascular Diseases,D002422: Causalgia,D002547: Cerebral Palsy,D003139: Common Cold,D003865: Depressive Disorder, Major,D003922: Diabetes Mellitus, Type 1,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D004646: Emphysema,D004828: Epilepsies, Partial,D005334: Fever,D005910: Glioma,D006105: Granulomatous Disease, Chronic,D006255: Rhinitis, Allergic, Seasonal,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007239: Infections,D007251: Influenza, Human,D008288: Malaria,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D010437: Peptic Ulcer,D010518: Periodontitis,D011225: Pre-Eclampsia,D011671: Pulpitis,D012128: Respiratory Distress Syndrome,D012178: Retinopathy of Prematurity,D012216: Rheumatic Diseases,D012772: Shock, Septic,D012852: Sinusitis,D013180: Sprains and Strains,D013281: Stomatitis, Aphthous,D013471: Sunburn,D013705: Temporomandibular Joint Disorders,D014076: Tooth Diseases,D014098: Toothache,D014376: Tuberculosis,D014627: Vaginitis,D014657: Vasculitis,D014947: Wounds and Injuries,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D018781: Tension-Type Headache,D019547: Neck Pain,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020388: Muscular Dystrophy, Duchenne,D020968: Brachial Plexus Neuritis,D025242: Spondylarthropathies,D047928: Premature Birth,D050723: Fractures, Bone,D055009: Spondylosis,D059350: Chronic Pain,D059787: Acute Pain,D060825: Cognitive Dysfunction,D063806: Myalgia,D064386: Ankle Fractures	PTGS2
P35354	NA	NA	NA	NA	PIROXICAM	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D005128: Eye Diseases,D010003: Osteoarthritis,D012216: Rheumatic Diseases,D013716: Tennis Elbow,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D056844: Renal Colic,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	PHENYLBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	FLURBIPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D003924: Diabetes Mellitus, Type 2,D005128: Eye Diseases,D010146: Pain,D010518: Periodontitis,D010612: Pharyngitis,D012216: Rheumatic Diseases,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D028361: Mitochondrial Diseases,D063806: Myalgia	PTGS2
P35354	CHEMBL112	16450	1983	DB00316	ACETAMINOPHEN	Cyclooxygenase inhibitor	INHIBITOR	1968	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000070636: Rotator Cuff Injuries,D000744: Anemia, Hemolytic, Autoimmune,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001883: Borderline Personality Disorder,D001924: Brain Concussion,D001930: Brain Injuries,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002972: Cleft Palate,D003139: Common Cold,D003424: Crohn Disease,D003693: Delirium,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004066: Digestive System Diseases,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D005334: Fever,D005901: Glaucoma,D005910: Glioma,D006009: Glycogen Storage Disease Type II,D006086: Graft vs Host Disease,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D006984: Hypertrophy,D007021: Hypospadias,D007154: Immune System Diseases,D007239: Infections,D007251: Influenza, Human,D007669: Kidney Calculi,D007674: Kidney Diseases,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008545: Melanoma,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009216: Myopia,D009325: Nausea,D009369: Neoplasms,D009422: Nervous System Diseases,D009437: Neuralgia,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010300: Parkinson Disease,D010392: Pemphigus,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011537: Pruritus,D011671: Pulpitis,D012141: Respiratory Tract Infections,D012600: Scoliosis,D012852: Sinusitis,D013290: Streptococcal Infections,D014069: Tonsillitis,D014076: Tooth Diseases,D014098: Toothache,D014839: Vomiting,D014947: Wounds and Injuries,D015207: Osteoarthritis, Hip,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015458: Leukemia, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D015746: Abdominal Pain,D016403: Lymphoma, Large B-Cell, Diffuse,D016553: Purpura, Thrombocytopenic, Idiopathic,D016920: Meningitis, Bacterial,D017116: Low Back Pain,D018781: Tension-Type Headache,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D052016: Mucositis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055959: Intervertebral Disc Degeneration,D056844: Renal Colic,D059350: Chronic Pain,D059787: Acute Pain,D064386: Ankle Fractures	PTGS2
P35354	NA	NA	NA	NA	SULINDAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D008545: Melanoma,D011125: Adenomatous Polyposis Coli,D011230: Precancerous Conditions,D012216: Rheumatic Diseases,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018222: Fibromatosis, Aggressive	PTGS2
P35354	NA	NA	NA	NA	FENCLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	KETOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D002062: Bursitis,D007249: Inflammation,D007669: Kidney Calculi,D008881: Migraine Disorders,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010518: Periodontitis,D012216: Rheumatic Diseases,D013180: Sprains and Strains,D014947: Wounds and Injuries,D017116: Low Back Pain,D018771: Arthralgia,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	INDOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1979	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	CELECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	1998	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000070636: Rotator Cuff Injuries,D000071960: Breast Carcinoma In Situ,D000077195: Squamous Cell Carcinoma of Head and Neck,D000081483: Squamous Intraepithelial Lesions,D000236: Adenoma,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004412: Dysmenorrhea,D004938: Esophageal Neoplasms,D005157: Facial Pain,D005909: Glioblastoma,D005910: Glioma,D006073: Gout,D006258: Head and Neck Neoplasms,D006470: Hemorrhage,D006527: Hepatolenticular Degeneration,D006528: Carcinoma, Hepatocellular,D006973: Hypertension,D007024: Hypotension, Orthostatic,D007249: Inflammation,D007251: Influenza, Human,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008527: Medulloblastoma,D008545: Melanoma,D008569: Memory Disorders,D008881: Migraine Disorders,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009437: Neuralgia,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010003: Osteoarthritis,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010212: Papilloma,D010265: Paraproteinemias,D010437: Peptic Ulcer,D010534: Peritoneal Neoplasms,D010612: Pharyngitis,D011125: Adenomatous Polyposis Coli,D011225: Pre-Eclampsia,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012216: Rheumatic Diseases,D012509: Sarcoma,D012559: Schizophrenia,D013167: Spondylitis, Ankylosing,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014098: Toothache,D014376: Tuberculosis,D014594: Uterine Neoplasms,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015207: Osteoarthritis, Hip,D016543: Central Nervous System Neoplasms,D017116: Low Back Pain,D018192: Lymphangioleiomyomatosis,D019052: Depression, Postpartum,D020370: Osteoarthritis, Knee,D030361: Papillomavirus Infections,D049970: Graves Ophthalmopathy,D055623: Keratosis, Actinic,D059350: Chronic Pain,D059787: Acute Pain,D060831: Hand-Foot Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2
P35354	NA	NA	NA	NA	MELOXICAM	Cyclooxygenase-2 inhibitor	INHIBITOR	2000	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D004412: Dysmenorrhea,D008180: Lupus Erythematosus, Systemic,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D014098: Toothache,D014376: Tuberculosis,D017116: Low Back Pain,D020069: Shoulder Pain	PTGS2
P35354	NA	NA	NA	NA	ROFECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	1999	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000236: Adenoma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D007592: Joint Diseases,D010003: Osteoarthritis,D010146: Pain,D012216: Rheumatic Diseases,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D020370: Osteoarthritis, Knee,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2
P35354	NA	NA	NA	NA	ETODOLAC	Cyclooxygenase-2 inhibitor	INHIBITOR	1991	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D006528: Carcinoma, Hepatocellular,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009135: Muscular Diseases,D010003: Osteoarthritis,D010146: Pain,D010190: Pancreatic Neoplasms,D012216: Rheumatic Diseases,D013180: Sprains and Strains,D015179: Colorectal Neoplasms,D059787: Acute Pain	PTGS2
P35354	NA	NA	NA	NA	DICLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000375: Aging,D001172: Arthritis, Rheumatoid,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D003866: Depressive Disorder,D005128: Eye Diseases,D007246: Infertility,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010518: Periodontitis,D011655: Pulmonary Embolism,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013180: Sprains and Strains,D013276: Stomach Ulcer,D014098: Toothache,D015207: Osteoarthritis, Hip,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D056844: Renal Colic,D059373: Mastodynia,D059787: Acute Pain,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	MEFENAMIC ACID	Cyclooxygenase inhibitor	INHIBITOR	1967	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003920: Diabetes Mellitus,D004412: Dysmenorrhea,D006470: Hemorrhage,D010146: Pain,D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	MESALAMINE	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000076385: Diverticular Diseases,D000236: Adenoma,D001607: Berylliosis,D003092: Colitis,D003093: Colitis, Ulcerative,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003424: Crohn Disease,D004238: Diverticulitis,D004241: Diverticulum, Colon,D011349: Proctitis,D015179: Colorectal Neoplasms,D015658: HIV Infections,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D046729: Colitis, Collagenous,D046730: Colitis, Lymphocytic	PTGS2
P35354	NA	NA	NA	NA	BROMFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1997	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	NAPROXEN	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D004381: Duodenal Ulcer,D004412: Dysmenorrhea,D006073: Gout,D006261: Headache,D007249: Inflammation,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D010437: Peptic Ulcer,D010996: Pleural Effusion,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D014627: Vaginitis,D015207: Osteoarthritis, Hip,D015210: Arthritis, Gouty,D017116: Low Back Pain,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D049310: Distal Myopathies,D059787: Acute Pain,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	VALDECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	2001	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D010612: Pharyngitis,D012216: Rheumatic Diseases,D020370: Osteoarthritis, Knee	PTGS2
P35354	NA	NA	NA	NA	DIFLUNISAL	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003924: Diabetes Mellitus, Type 2,D005334: Fever,D010146: Pain,D028227: Amyloid Neuropathies, Familial	PTGS2
P35354	NA	NA	NA	NA	SUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	NEPAFENAC	Cyclooxygenase inhibitor	INHIBITOR	2005	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D002386: Cataract,D005128: Eye Diseases,D007249: Inflammation,D008269: Macular Edema,D015877: Miosis	PTGS2
P35354	NA	NA	NA	NA	DICLOFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D001749: Urinary Bladder Neoplasms,D006073: Gout,D006470: Hemorrhage,D007249: Inflammation,D009135: Muscular Diseases,D010003: Osteoarthritis,D010032: Otitis Externa,D010146: Pain,D011843: Radiculopathy,D013180: Sprains and Strains,D013471: Sunburn,D014098: Toothache,D017116: Low Back Pain,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D059350: Chronic Pain	PTGS2
P35354	NA	NA	NA	NA	NABUMETONE	Cyclooxygenase-2 inhibitor	INHIBITOR	1991	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	OXAPROZIN	Cyclooxygenase inhibitor	INHIBITOR	1992	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	BISMUTH SUBSALICYLATE	Cyclooxygenase inhibitor	INHIBITOR	1996	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D008223: Lymphoma,D016481: Helicobacter Infections	PTGS2
P35354	NA	NA	NA	NA	CARPROFEN	Cyclooxygenase-2 inhibitor	INHIBITOR	1987	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	PIRPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2
P35354	NA	NA	NA	NA	OXAPROZIN POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	2002	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	TOLMETIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	BALSALAZIDE DISODIUM	Cyclooxygenase inhibitor	INHIBITOR	2000	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003093: Colitis, Ulcerative	PTGS2
P35354	NA	NA	NA	NA	DICLOFENAC POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	1993	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D004412: Dysmenorrhea,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D011671: Pulpitis,D013276: Stomach Ulcer,D014098: Toothache,D059787: Acute Pain	PTGS2
P35354	NA	NA	NA	NA	NAPROXEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D002062: Bursitis,D004412: Dysmenorrhea,D006073: Gout,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D059787: Acute Pain	PTGS2
P35354	NA	NA	NA	NA	OLSALAZINE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1990	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003093: Colitis, Ulcerative	PTGS2
P35354	NA	NA	NA	NA	KETOROLAC TROMETHAMINE	Cyclooxygenase inhibitor	INHIBITOR	1989	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001416: Back Pain,D002386: Cataract,D002539: Cerebral Arterial Diseases,D006255: Rhinitis, Allergic, Seasonal,D006331: Heart Diseases,D007249: Inflammation,D007669: Kidney Calculi,D008269: Macular Edema,D008881: Migraine Disorders,D010146: Pain,D011671: Pulpitis,D019534: Shoulder Impingement Syndrome,D056844: Renal Colic,D059787: Acute Pain	PTGS2
P35354	NA	NA	NA	NA	IBUPROFEN LYSINE	Cyclooxygenase inhibitor	INHIBITOR	2006	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D004374: Ductus Arteriosus, Patent	PTGS2
P35354	NA	NA	NA	NA	DICLOFENAC EPOLAMINE	Cyclooxygenase inhibitor	INHIBITOR	2007	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001943: Breast Neoplasms,D010195: Pancreatitis,D013180: Sprains and Strains,D059787: Acute Pain	PTGS2
P35354	NA	NA	NA	NA	MECLOFENAMATE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	FENOPROFEN CALCIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P35354	NA	NA	NA	NA	IBUPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	2012	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D010146: Pain	PTGS2
P35354	NA	NA	NA	NA	INDOMETHACIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D007249: Inflammation	PTGS2
P35354	NA	NA	NA	NA	OXYPHENBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1960	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D005128: Eye Diseases,D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS2
P35354	NA	NA	NA	NA	FLURBIPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2
P40238	NA	NA	NA	NA	ROMIPLOSTIM	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D002277: Carcinoma,D006470: Hemorrhage,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011696: Purpura, Thrombocytopenic,D011697: Purpura, Thrombotic Thrombocytopenic,D013921: Thrombocytopenia,D014923: Wiskott-Aldrich Syndrome,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL
P40238	NA	NA	NA	NA	AVATROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D001791: Blood Platelet Disorders,D006470: Hemorrhage,D008107: Liver Diseases,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL
P40238	NA	NA	NA	NA	AVATROMBOPAG MALEATE	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D013921: Thrombocytopenia	MPL
P40238	NA	NA	NA	NA	LUSUTROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D006470: Hemorrhage,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL
P40238	NA	NA	NA	NA	ELTROMBOPAG OLAMINE	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D009190: Myelodysplastic Syndromes,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic,D019698: Hepatitis C, Chronic	MPL
Q7L0J3	NA	NA	NA	NA	LEVETIRACETAM	Synaptic vesicle glycoprotein 2A modulator	MODULATOR	1999	CHEMBL1998	31000	Q7L0J3	Synaptic vesicle glycoprotein 2A	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001037: Aphasia,D001714: Bipolar Disorder,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D005909: Glioblastoma,D005910: Glioma,D006562: Herpes Zoster,D009069: Movement Disorders,D009293: Opioid-Related Disorders,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011115: Polyneuropathies,D011618: Psychotic Disorders,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D013375: Substance Withdrawal Syndrome,D014103: Torticollis,D015470: Leukemia, Myeloid, Acute,D016584: Panic Disorder,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020329: Essential Tremor,D020521: Stroke,D060825: Cognitive Dysfunction	SV2A
Q7L0J3	NA	NA	NA	NA	BRIVARACETAM	Synaptic vesicle glycoprotein 2A modulator	MODULATOR	2016	CHEMBL1998	31000	Q7L0J3	Synaptic vesicle glycoprotein 2A	Homo sapiens	D004827: Epilepsy,D006562: Herpes Zoster,D012640: Seizures,D013119: Spinal Cord Injuries,D020194: Unverricht-Lundborg Syndrome	SV2A
P43115	NA	NA	NA	NA	DINOPROSTONE	Prostaglandin E2 receptor agonist	AGONIST	1977	CHEMBL2363068	105763	P43115	Prostaglandin E2 receptor EP3 subtype	Homo sapiens	D010146: Pain,D011247: Pregnancy	PTGER3
P43115	NA	NA	NA	NA	MISOPROSTOL	Prostanoid EP3 receptor agonist	AGONIST	1988	CHEMBL3710	10329	P43115	Prostaglandin E2 receptor EP3 subtype	Homo sapiens	D000022: Abortion, Spontaneous,D000027: Abortion, Incomplete,D003015: Clostridium Infections,D005764: Gastroesophageal Reflux,D006470: Hemorrhage,D006473: Postpartum Hemorrhage,D007239: Infections,D007889: Leiomyoma,D008595: Menorrhagia,D009120: Muscle Cramp,D009765: Obesity,D010003: Osteoarthritis,D010146: Pain,D010437: Peptic Ulcer,D011225: Pre-Eclampsia,D011247: Pregnancy,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014591: Uterine Diseases,D047928: Premature Birth	PTGER3
P47901	NA	NA	NA	NA	VASOPRESSIN	Vasopressin receptor agonist	AGONIST	2014	CHEMBL2363078	105773	P47901	Vasopressin V1b receptor	Homo sapiens	D001321: Autistic Disorder,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003919: Diabetes Insipidus,D006323: Heart Arrest,D006331: Heart Diseases,D006976: Hypertension, Pulmonary,D007022: Hypotension,D007889: Leiomyoma,D009214: Myoma,D010146: Pain,D010996: Pleural Effusion,D012769: Shock,D012772: Shock, Septic,D016757: Death, Sudden, Cardiac,D018805: Sepsis,D055371: Acute Lung Injury,D065630: Hernias, Diaphragmatic, Congenital	AVPR1B
P47901	NA	NA	NA	NA	DESMOPRESSIN ACETATE	Vasopressin receptor agonist	AGONIST	1978	CHEMBL2363078	105773	P47901	Vasopressin V1b receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D006470: Hemorrhage,D006973: Hypertension,D011183: Postoperative Complications	AVPR1B
P47901	NA	NA	NA	NA	LYPRESSIN	Vasopressin receptor agonist	AGONIST	1982	CHEMBL2363078	105773	P47901	Vasopressin V1b receptor	Homo sapiens	NA	AVPR1B
P47901	NA	NA	NA	NA	VASOPRESSIN TANNATE	Vasopressin V1b receptor agonist	AGONIST	1982	CHEMBL1921	148	P47901	Vasopressin V1b receptor	Homo sapiens	NA	AVPR1B
